<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PeerJ</journal-id><journal-id journal-id-type="iso-abbrev">PeerJ</journal-id><journal-id journal-id-type="pmc">PeerJ</journal-id><journal-id journal-id-type="publisher-id">PeerJ</journal-id><journal-title-group><journal-title>PeerJ</journal-title></journal-title-group><issn pub-type="epub">2167-8359</issn><publisher><publisher-name>PeerJ Inc.</publisher-name><publisher-loc>San Diego, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31598423</article-id><article-id pub-id-type="pmc">6779144</article-id><article-id pub-id-type="publisher-id">7705</article-id><article-id pub-id-type="doi">10.7717/peerj.7705</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bioinformatics</subject></subj-group><subj-group subj-group-type="heading"><subject>Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Oncology</subject></subj-group></article-categories><title-group><article-title>The clinical significance of collagen family gene expression in esophageal squamous cell carcinoma</article-title></title-group><contrib-group><contrib id="author-1" contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Jieling</given-names></name><xref ref-type="aff" rid="aff-1">1</xref></contrib><contrib id="author-2" contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Xiao</given-names></name><xref ref-type="aff" rid="aff-2">2</xref></contrib><contrib id="author-3" contrib-type="author"><name><surname>Zheng</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="aff-1">1</xref></contrib><contrib id="author-4" contrib-type="author"><name><surname>Liu</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff-2">2</xref></contrib><contrib id="author-5" contrib-type="author"><name><surname>Li</surname><given-names>Junjun</given-names></name><xref ref-type="aff" rid="aff-1">1</xref></contrib><contrib id="author-6" contrib-type="author"><name><surname>Wang</surname><given-names>Shaoqi</given-names></name><xref ref-type="aff" rid="aff-3">3</xref></contrib><contrib id="author-7" contrib-type="author"><name><surname>Liu</surname><given-names>Kaisheng</given-names></name><xref ref-type="aff" rid="aff-2">2</xref></contrib><contrib id="author-8" contrib-type="author"><name><surname>Song</surname><given-names>Xun</given-names></name><xref ref-type="aff" rid="aff-1">1</xref></contrib><contrib id="author-9" contrib-type="author"><name><surname>Li</surname><given-names>Nan</given-names></name><xref ref-type="aff" rid="aff-2">2</xref></contrib><contrib id="author-10" contrib-type="author" corresp="yes"><name><surname>Xie</surname><given-names>Shouxia</given-names></name><xref ref-type="aff" rid="aff-2">2</xref><email>szshouxia@163.com</email></contrib><contrib id="author-11" contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Shaoxiang</given-names></name><xref ref-type="aff" rid="aff-1">1</xref><email>wsx@szu.edu.cn</email></contrib><aff id="aff-1">
<label>1</label><institution>School of Pharmaceutical Sciences, Shenzhen University Health Science Center</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff><aff id="aff-2">
<label>2</label><institution>Department of Pharmacy, The Second Clinical Medical College (Shenzhen People&#x02019;s Hospital), Jinan University</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff><aff id="aff-3">
<label>3</label><institution>Department of Oncology, Hubei Provincial Corps Hospital, Chinese People Armed Police Forces</institution>, <addr-line>Wuhan</addr-line>, <country>China</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Kumar</surname><given-names>Abhishek</given-names></name></contrib></contrib-group><pub-date pub-type="epub" date-type="pub" iso-8601-date="2019-10-04"><day>4</day><month>10</month><year iso-8601-date="2019">2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>7</volume><elocation-id>e7705</elocation-id><history><date date-type="received" iso-8601-date="2019-03-20"><day>20</day><month>3</month><year iso-8601-date="2019">2019</year></date><date date-type="accepted" iso-8601-date="2019-08-19"><day>19</day><month>8</month><year iso-8601-date="2019">2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Li et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Li et al.</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license></permissions><self-uri xlink:href="https://peerj.com/articles/7705"/><abstract><sec><title>Background</title><p>Esophageal squamous cell carcinoma (ESCC) is a subtype of esophageal cancer with high incidence and mortality. Due to the poor 5-year survival rates of patients with ESCC, exploring novel diagnostic markers for early ESCC is emergent. Collagen, the abundant constituent of extracellular matrix, plays a critical role in tumor growth and epithelial-mesenchymal transition. However, the clinical significance of collagen genes in ESCC has been rarely studied. In this work, we systematically analyzed the gene expression of whole collagen family in ESCC, aiming to search for ideal biomarkers.</p></sec><sec><title>Methods</title><p>Clinical data and gene expression profiles of ESCC patients were collected from The Cancer Genome Atlas and the gene expression omnibus databases. Bioinformatics methods, including differential expression analysis, survival analysis, gene sets enrichment analysis (GSEA) and co-expression network analysis, were performed to investigate the correlation between the expression patterns of 44 collagen family genes and the development of ESCC.</p></sec><sec><title>Results</title><p>A total of 22 genes of collagen family were identified as differentially expressed genes in both the two datasets. Among them, COL1A1, COL10A1 and COL11A1 were particularly up-regulated in ESCC tissues compared to normal controls, while COL4A4, COL6A5 and COL14A1 were notably down-regulated. Besides, patients with low COL6A5 expression or high COL18A1 expression showed poor survival. In addition, a 7-gene prediction model was established based on collagen gene expression to predict patient survival, which had better predictive accuracy than the tumor-node-metastasis staging based model. Finally, GSEA results suggested that collagen genes might be tightly associated with PI3K/Akt/mTOR pathway, p53 pathway, apoptosis, cell cycle, etc.</p></sec><sec><title>Conclusion</title><p>Several collagen genes could be potential diagnostic and prognostic biomarkers for ESCC. Moreover, a novel 7-gene prediction model is probably useful for predicting survival outcomes of ESCC patients. These findings may facilitate early detection of ESCC and help improves prognosis of the patients.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>ESCC</kwd><kwd>TCGA</kwd><kwd>GEO</kwd><kwd>Gene expression</kwd><kwd>Overall survival</kwd><kwd>Collagen</kwd></kwd-group><funding-group><award-group id="fund-1"><funding-source>National Natural Science Foundation of China</funding-source><award-id>81602625</award-id></award-group><award-group id="fund-2"><funding-source>Natural Science Foundation of Guangdong Province</funding-source><award-id>2016A030310096, 2018A030313122</award-id></award-group><award-group id="fund-3"><funding-source>Science and Technology Planning Project of Guangdong Province</funding-source><award-id>2017A010105013</award-id></award-group><award-group id="fund-4"><funding-source>Pearl River S&#x00026;T Nova Program of Guangzhou</funding-source><award-id>201710010011</award-id></award-group><award-group id="fund-5"><funding-source>Shenzhen Science and Technology Project</funding-source><award-id>JCYJ20170302145059926, JCYJ20180305163658916, JCYJ20180228175059744</award-id></award-group><funding-statement>This work was financially supported by the National Natural Science Foundation of China (Nos. 81602625), the Natural Science Foundation of Guangdong Province (2016A030310096, 2018A030313122), the Science and Technology Planning Project of Guangdong Province (2017A010105013), the Pearl River S&#x00026;T Nova Program of Guangzhou (201710010011), and the Shenzhen Science and Technology Project (JCYJ20170302145059926, JCYJ20180305163658916, JCYJ20180228175059744). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Esophageal cancer is the seventh most commonly diagnosed cancer and the sixth leading cause of cancer death (<xref rid="ref-3" ref-type="bibr">Bray et al., 2018</xref>). It is classified into two histological subtypes, esophageal adenocarcinoma and esophageal squamous cell carcinoma (ESCC), the latter of which is the predominant type worldwide (<xref rid="ref-37" ref-type="bibr">Pennathur et al., 2013</xref>). Despite the effective treatments (e.g., surgery, chemotherapy and radiotherapy) for ESCC, the 5-year survival rates of patients with advanced ESCC are still less than 20% (<xref rid="ref-7" ref-type="bibr">Codipilly et al., 2018</xref>). However, the survival rates could be improved to over 80% if patients were diagnosed with an early stage (<xref rid="ref-23" ref-type="bibr">Lao-Sirieix &#x00026; Fitzgerald, 2012</xref>; <xref rid="ref-56" ref-type="bibr">Wang et al., 2004</xref>). Although a few tumor markers, carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen, have been used in the diagnosis of ESCC, they are not suitable for early detection due to the lack of sensitivity (<xref rid="ref-21" ref-type="bibr">Kosugi et al., 2004</xref>). Thus, it is urgent to search for novel biomarkers to help early detection of ESCC and improve survival rates of the patients.</p><p>Collagen is the most abundant extracellular matrix protein that promotes cell growth and provides mechanical resilience of connective tissues (<xref rid="ref-51" ref-type="bibr">Sorushanova et al., 2018</xref>). The collagen family comprises 28 types with different &#x003b1; chains encoded by more than 40 genes (<xref rid="ref-42" ref-type="bibr">Ricard-Blum, 2011</xref>). It has been reported that the expression of collagen-encoding genes was significantly related to the prognosis of certain types of cancers (<xref rid="ref-14" ref-type="bibr">Giussani et al., 2018</xref>; <xref rid="ref-27" ref-type="bibr">Liu et al., 2018</xref>; <xref rid="ref-45" ref-type="bibr">Rong et al., 2018</xref>; <xref rid="ref-48" ref-type="bibr">Shen et al., 2016</xref>; <xref rid="ref-62" ref-type="bibr">Zhang et al., 2018c</xref>). In addition, a couple of collagen genes, such as COL11A1 and COL6A1, were expressed aberrantly in ESCC tissues and possibly affected the progression of ESCC (<xref rid="ref-10" ref-type="bibr">Fan et al., 2012</xref>; <xref rid="ref-16" ref-type="bibr">He et al., 2017</xref>; <xref rid="ref-64" ref-type="bibr">Zhang et al., 2018a</xref>). However, most of these works focused on specific collagen genes, and the potential roles of other members remain to be clarified.</p><p>Here, we provided a systematic analysis of gene expression of the whole collagen family and its corresponding clinical significance in ESCC. Clinical data and gene expression profiles of ESCC patients were extracted from The Cancer Genome Atlas (TCGA) and the gene expression omnibus (GEO), two public databases with substantial information about cancers. Different bioinformatics methods, including differential expression analysis, survival analysis, pathway analysis and co-expression network analysis were used to analyze the data to sift important hits possibly involved in the initiation and development of ESCC. According to collagen family genes, we also established a prediction model with high performance to predict the prognosis of ESCC patients. Collectively, our works mainly explored the relation of collagen gene expression to ESCC and illuminated the potential mechanism.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Patient data</title><p>Basic data of ESCC patients were downloaded from the TCGA database (<uri xlink:href="https://portal.gdc.cancer.gov/">https://portal.gdc.cancer.gov/</uri>) and the <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53625">GSE53625</uri> dataset of the GEO database; 95 cases from TCGA and 179 cases from <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53625">GSE53625</uri>. Univariate and multivariate Cox regression analyses were carried out to investigate the correlation between overall survival and clinicopathological characteristics of the patients by SPSS (v23.0). The relations between collagen family gene expression and clinicopathological characteristics of the patients were examined using Pearson correlation analysis via SPSS.</p></sec><sec><title>Differential expression analysis</title><p>Gene expression profiles of tumor and adjacent normal tissues in ESCC patients were also obtained from the two datasets. 81 of 95 patient cases in TCGA and all patient cases in GEO had RNA-sequence data. In total, 81 tumor samples with 11 normal controls from TCGA and 179 tumor samples with 179 normal controls from GEO (<xref rid="ref-25" ref-type="bibr">Li et al., 2014</xref>) were included in analysis (each sample was taken from a different patient). Differential expression analysis was conducted using the edgeR (<xref rid="ref-44" ref-type="bibr">Robinson, McCarthy &#x00026; Smyth, 2010</xref>) and the limma (<xref rid="ref-43" ref-type="bibr">Ritchie et al., 2015</xref>) packages, respectively, for TCGA and GEO data by R software (<xref rid="ref-67" ref-type="bibr">R Core Team, 2018</xref>). Gene expression levels were normalized by the calcNormFactors function in edgeR (<xref rid="ref-24" ref-type="bibr">Law et al., 2016</xref>) and by the normalizeBetweenArrays function in limma (<xref rid="ref-49" ref-type="bibr">Smyth &#x00026; Speed, 2003</xref>), to make sure the expression distributions of each sample are similar across the entire matrix. Then based on the exact test in edgeR which is analogous to Fisher&#x02019;s exact test (<xref rid="ref-44" ref-type="bibr">Robinson, McCarthy &#x00026; Smyth, 2010</xref>) and the Empirical Bayes statistical test in limma (<xref rid="ref-41" ref-type="bibr">Phipson et al., 2016</xref>), fold change, <italic>P</italic>-value and false discovery rate (FDR) (or adjusted <italic>P</italic>-value) were figured out to show the expression difference between tumor and normal samples. Genes with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.05 were considered as differentially expressed genes (DEGs). Accordingly, DEGs of collagen family were identified. Then heatmaps, boxplots and Venn diagram were drawn by R software.</p></sec><sec><title>Survival analysis</title><p>First, hazard ratio (HR) and <italic>P</italic>-value of each DEG of collagen family were figured out based on gene expression and overall survival of patients by the univariate Cox regression model with the survival package through R software. The HR is an estimate of the ratio of the hazard rate in the treated versus the control group (<xref rid="ref-52" ref-type="bibr">Spruance et al., 2004</xref>), while in this study it is defined as the hazard in the high expression group divided by the hazard in the low expression group. HR &#x0003e; 1 and HR &#x0003c; 1 mean higher expression of the gene is associated with worse and better overall survival, respectively. Survival curves were plotted according to the Kaplan&#x02013;Meier method and compared by the log-rank test using the survival and the <italic>q</italic>-value packages in R. <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec><sec><title>Prediction models</title><p>Prediction models were established to predict patient survival based on gene expression of 22 DEGs of collagen family and overall survival of patients by the multivariate Cox regress analysis with the survival package via R software. Several candidate genes were eventually selected out by the analysis to form the model, with a formula calculating the risk score of each patient. The general formula is given below:
<disp-formula id="eqn-1"><label>(1)</label><alternatives><graphic xlink:href="peerj-07-7705-e001.jpg" mimetype="image" mime-subtype="png" position="float" orientation="portrait"/><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$${\rm Risk\; score} = \mathop \sum \limits_{i = 1}^n {\rm Coe}{{\rm f}_i} \times {\rm Ex}{{\rm p}_i}$$\end{document}</tex-math><mml:math id="mml-eqn-1"><mml:mrow><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">k</mml:mi><mml:mspace width="thickmathspace"/><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mrow><mml:mo movablelimits="false">&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover><mml:mo>&#x02061;</mml:mo><mml:mrow><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">f</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>&#x000d7;</mml:mo><mml:mrow><mml:mi mathvariant="normal">E</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="normal">p</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></alternatives></disp-formula>
where <italic>n</italic>, Coef and Exp indicate the number of included genes, the coefficient of each gene, and gene expression level, respectively. The coefficients were estimated based on the relative contributions of each collagen gene. A patient&#x02019;s risk score was calculated as the sum of the expression levels of each gene multiplied by its corresponding coefficient. Similar methods have been adopted by earlier studies (<xref rid="ref-2" ref-type="bibr">Beer et al., 2002</xref>; <xref rid="ref-28" ref-type="bibr">Lossos et al., 2004</xref>; <xref rid="ref-57" ref-type="bibr">Wang et al., 2018</xref>). Then, receiver operating characteristic (ROC) curves were plotted based on the risk scores and overall survival of patients by the survivalROC package in R, with area under curve (AUC) values which represented the accuracy of predicting 3-year survival. Also, survival curves were obtained by dividing the patients into high- and low-risk groups according to the median risk score using the survival package.</p></sec><sec><title>Pathway analysis</title><p>Potential mechanism of collagen family genes was explored by the gene sets enrichment analysis (GSEA), a method to determine whether members of a previously defined gene set are correlated with the phenotypic class distinction (<xref rid="ref-53" ref-type="bibr">Subramanian et al., 2005</xref>). GSEA was conducted using the gene expression profiles of patients&#x02019; tumor samples via javaGSEA software (<uri xlink:href="http://software.broadinstitute.org/gsea/downloads.jsp">http://software.broadinstitute.org/gsea/downloads.jsp</uri>), and the patient samples were divided into high- and low-risk groups in half according to the risk scores obtained by the collagen-DEGs-based prediction models (<xref rid="ref-4" ref-type="bibr">Chai et al., 2018</xref>; <xref rid="ref-65" ref-type="bibr">Zhang et al., 2017</xref>; <xref rid="ref-66" ref-type="bibr">Zhao et al., 2017</xref>). Oncogenic Signatures Gene Sets (v6.2), Hallmark Gene Sets (v6.2) and KEGG Gene Sets (v6.2) (<uri xlink:href="http://software.broadinstitute.org/gsea/msigdb/collections.jsp">http://software.broadinstitute.org/gsea/msigdb/collections.jsp</uri>) were, respectively, used as references. Based on these gene sets databases, the expression profiles were analyzed to find out if a set of genes were mostly up-regulated (or down-regulated) in the high-risk group (or low-risk group). Normalized enrichment score reflected the degree to which a gene set was overrepresented in the groups, and gene sets in the results with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered as significant ones (<xref rid="ref-53" ref-type="bibr">Subramanian et al., 2005</xref>).</p></sec><sec><title>Co-expression network analysis</title><p>Patients&#x02019; tumor samples from TCGA were separated into high- and low-risk groups by the risk scores calculated by the 7-gene prediction model. Risk-score-based DEGs that were differentially expressed between the two groups were determined using the gene expression profiles of tumor samples by the same method as differential expression analysis. Then the relationships between collagen family genes and the risk-score-based DEGs as well as the representative enriched gene sets from GSEA were assessed by the Weighted Gene Co-Expression Network Analysis (WCGNA) with the WGCNA package through R software, which is a method to describe the correlation patterns among genes across different samples (<xref rid="ref-22" ref-type="bibr">Langfelder &#x00026; Horvath, 2008</xref>). Genes of each gene set were extracted from <uri xlink:href="http://software.broadinstitute.org/gsea/msigdb/genesets.jsp">http://software.broadinstitute.org/gsea/msigdb/genesets.jsp</uri>. Finally, the genes co-expressed with collagen family genes were obtained, and the networks of them were drawn via Cytoscape (<uri xlink:href="http://www.cytoscape.org/">http://www.cytoscape.org/</uri>, v3.7.1).</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Clinicopathological information of the ESCC patients</title><p>A total of 95 patient cases in TCGA and 179 cases in GEO were collected and analyzed by univariate and multivariate Cox regression analyses. As a result, poor overall survival was significantly correlated with sex, tumor-node-metastasis (TNM) stage and N stage in TCGA (<italic>P</italic> = 0.020, <italic>P</italic> = 0.015, and <italic>P</italic> = 0.012, respectively) (<xref rid="table-1" ref-type="table">Table 1</xref>), and was notably associated with age, TNM stage and N stage in GEO (<italic>P</italic> = 0.021, <italic>P</italic> &#x0003c; 0.001, and <italic>P</italic> = 0.030, respectively) (<xref rid="table-2" ref-type="table">Table 2</xref>). Besides, investigation into the correlation between collagen family gene expression and the clinicopathological characteristics revealed that the expression of several collagen genes was significantly related to advanced TNM stages or tumor grades. (<xref rid="table-3" ref-type="table">Tables 3</xref> and <xref rid="table-4" ref-type="table">4</xref>).</p><table-wrap id="table-1" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/table-1</object-id><label>Table 1</label><caption><title>Univariate and multivariate analyses of clinicopathological characteristics for overall survival in ESCC patients from the TCGA dataset (<italic>N</italic> = 95).</title></caption><alternatives><graphic xlink:href="peerj-07-7705-g006"/><table frame="hsides" rules="groups" content-type="text"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Variables</th><th rowspan="2" colspan="1"><italic>n</italic> (%)</th><th colspan="2" rowspan="1">Univariate analysis</th><th colspan="2" rowspan="1">Multivariate analysis</th></tr><tr><th rowspan="1" colspan="1">HR (95% CI)</th><th rowspan="1" colspan="1"><italic>P</italic></th><th rowspan="1" colspan="1">HR (95% CI)</th><th rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;&#x0003c;60</td><td rowspan="1" colspan="1">56 (58.9%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;&#x02265;60</td><td rowspan="1" colspan="1">39 (41.1%)</td><td rowspan="1" colspan="1">1.296 [0.631&#x02013;2.662]</td><td rowspan="1" colspan="1">0.461</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Male</td><td rowspan="1" colspan="1">80 (84.2%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Female</td><td rowspan="1" colspan="1">15 (15.8%)</td><td rowspan="1" colspan="1">0.175 [0.041&#x02013;0.756]</td><td rowspan="1" colspan="1">0.020</td><td rowspan="1" colspan="1">0.206 [0.043&#x02013;0.978]</td><td rowspan="1" colspan="1">0.047</td></tr><tr><td rowspan="1" colspan="1">TNM Stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;I + II</td><td rowspan="1" colspan="1">63 (66.3%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;III + IV</td><td rowspan="1" colspan="1">31 (32.6%)</td><td rowspan="1" colspan="1">2.443 [1.191&#x02013;5.011]</td><td rowspan="1" colspan="1">0.015</td><td rowspan="1" colspan="1">0.921 [0.321&#x02013;2.643]</td><td rowspan="1" colspan="1">0.879</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">1 (1.1%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">T Stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;T1 + T2</td><td rowspan="1" colspan="1">40 (42.1%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;T3 + T4</td><td rowspan="1" colspan="1">54 (56.8%)</td><td rowspan="1" colspan="1">1.351 [0.649&#x02013;2.811]</td><td rowspan="1" colspan="1">0.422</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">1 (1.1%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Tumor grade</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;G1 + G2</td><td rowspan="1" colspan="1">65 (68.4%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;G3</td><td rowspan="1" colspan="1">21 (22.1%)</td><td rowspan="1" colspan="1">0.736 [0.277&#x02013;1.950]</td><td rowspan="1" colspan="1">0.537</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">9 (9.5%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">N Stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;N0 + N1</td><td rowspan="1" colspan="1">84 (88.4%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;N2 + N3</td><td rowspan="1" colspan="1">9 (9.5%)</td><td rowspan="1" colspan="1">3.265 [1.302&#x02013;8.189]</td><td rowspan="1" colspan="1">0.012</td><td rowspan="1" colspan="1">6.738 [1.493&#x02013;30.399]</td><td rowspan="1" colspan="1">0.013</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">2 (2.1%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Tumor location</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Upper + Middle</td><td rowspan="1" colspan="1">50 (52.6%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Lower</td><td rowspan="1" colspan="1">44 (46.3%)</td><td rowspan="1" colspan="1">0.958 [0.448&#x02013;2.051]</td><td rowspan="1" colspan="1">0.913</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">1 (1.1%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Alcohol use</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;No</td><td rowspan="1" colspan="1">25 (26.3%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Yes</td><td rowspan="1" colspan="1">68 (71.6%)</td><td rowspan="1" colspan="1">2.172 [0.751&#x02013;6.276]</td><td rowspan="1" colspan="1">0.152</td><td rowspan="1" colspan="1">4.755 [1.054&#x02013;21.457]</td><td rowspan="1" colspan="1">0.043</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">2 (2.1%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Tobacco use</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;No</td><td rowspan="1" colspan="1">44 (46.3%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Yes</td><td rowspan="1" colspan="1">51 (53.7%)</td><td rowspan="1" colspan="1">1.965 [0.901&#x02013;4.285]</td><td rowspan="1" colspan="1">0.089</td><td rowspan="1" colspan="1">1.095 [0.440&#x02013;2.725)</td><td rowspan="1" colspan="1">0.845</td></tr><tr><td rowspan="1" colspan="1">Race</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Asian</td><td rowspan="1" colspan="1">45 (47.4%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;White + Other</td><td rowspan="1" colspan="1">47 (49.5%)</td><td rowspan="1" colspan="1">1.570 [0.688&#x02013;3.581]</td><td rowspan="1" colspan="1">0.284</td><td rowspan="1" colspan="1">2.021 [0.782&#x02013;5.223]</td><td rowspan="1" colspan="1">0.146</td></tr><tr><td rowspan="1" colspan="1">&#x02002;Missing</td><td rowspan="1" colspan="1">3 (3.2%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-1fn"><p><bold>Notes:</bold></p></fn><fn id="table-1fn1" fn-type="other"><p>Characteristics with <italic>P</italic> &#x0003c; 0.3 in the univariate analysis were further screened in the multivariate analysis.</p></fn><fn id="table-1fn2" fn-type="other"><p>HR, hazard ratio; CI, confidence interval; TNM stage, tumor-node-metastasis stage; T stage, stage of tumor invasion; N stage, stage of regional lymph node invasion.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table-2" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/table-2</object-id><label>Table 2</label><caption><title>Univariate and multivariate analyses of clinicopathological characteristics for overall survival in ESCC patients from the GEO dataset (<italic>N</italic> = 179).</title></caption><alternatives><graphic xlink:href="peerj-07-7705-g007"/><table frame="hsides" rules="groups" content-type="text"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="2" colspan="1">Variables</th><th rowspan="2" colspan="1"><italic>n</italic> (%)</th><th colspan="2" rowspan="1">Univariate analysis</th><th colspan="2" rowspan="1">Multivariate analysis</th></tr><tr><th rowspan="1" colspan="1">HR (95% CI)</th><th rowspan="1" colspan="1"><italic>P</italic></th><th rowspan="1" colspan="1">HR (95% CI)</th><th rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;&#x0003c;60</td><td rowspan="1" colspan="1">91 (50.8%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;&#x02265;60</td><td rowspan="1" colspan="1">88 (49.2%)</td><td rowspan="1" colspan="1">1.574 [1.072&#x02013;2.311]</td><td rowspan="1" colspan="1">0.021</td><td rowspan="1" colspan="1">1.451 [0.980&#x02013;2.147]</td><td rowspan="1" colspan="1">0.063</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Male</td><td rowspan="1" colspan="1">146 (81.6%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Female</td><td rowspan="1" colspan="1">33 (18.4%)</td><td rowspan="1" colspan="1">1.277 [0.798&#x02013;2.044]</td><td rowspan="1" colspan="1">0.307</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">TNM Stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;I + II</td><td rowspan="1" colspan="1">87 (48.6%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;III + IV</td><td rowspan="1" colspan="1">92 (51.4%)</td><td rowspan="1" colspan="1">2.155 [1.448&#x02013;3.207]</td><td rowspan="1" colspan="1">&#x0003c;0.001</td><td rowspan="1" colspan="1">2.066 [1.322&#x02013;3.228]</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">T Stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;T1 + T2</td><td rowspan="1" colspan="1">39 (21.8%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;T3 + T4</td><td rowspan="1" colspan="1">140 (78.2%)</td><td rowspan="1" colspan="1">1.091 [0.687&#x02013;1.732]</td><td rowspan="1" colspan="1">0.712</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Tumor grade</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;G1 + G2</td><td rowspan="1" colspan="1">99 (55.3%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;G3</td><td rowspan="1" colspan="1">80 (44.7%)</td><td rowspan="1" colspan="1">1.391 [0.951&#x02013;2.037]</td><td rowspan="1" colspan="1">0.089</td><td rowspan="1" colspan="1">1.269 [0.860&#x02013;1.873]</td><td rowspan="1" colspan="1">0.230</td></tr><tr><td rowspan="1" colspan="1">N Stage</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;N0 + N1</td><td rowspan="1" colspan="1">145 (81.0%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;N2 + N3</td><td rowspan="1" colspan="1">34 (19.0%)</td><td rowspan="1" colspan="1">1.644 [1.048&#x02013;2.577]</td><td rowspan="1" colspan="1">0.030</td><td rowspan="1" colspan="1">1.062 [0.644&#x02013;1.751]</td><td rowspan="1" colspan="1">0.814</td></tr><tr><td rowspan="1" colspan="1">Tumor location</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Upper + Middle</td><td rowspan="1" colspan="1">117 (65.4%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Lower</td><td rowspan="1" colspan="1">62 (34.6%)</td><td rowspan="1" colspan="1">0.823 [0.546&#x02013;1.242]</td><td rowspan="1" colspan="1">0.354</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Alcohol use</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;No</td><td rowspan="1" colspan="1">73 (40.8%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Yes</td><td rowspan="1" colspan="1">106 (59.2%)</td><td rowspan="1" colspan="1">0.864 [0.588&#x02013;1.269]</td><td rowspan="1" colspan="1">0.456</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Tobacco use</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;No</td><td rowspan="1" colspan="1">65 (36.3%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Yes</td><td rowspan="1" colspan="1">114 (63.7%)</td><td rowspan="1" colspan="1">0.749 [0.508&#x02013;1.105]</td><td rowspan="1" colspan="1">0.145</td><td rowspan="1" colspan="1">0.753 [0.505&#x02013;1.122]</td><td rowspan="1" colspan="1">0.163</td></tr><tr><td rowspan="1" colspan="1">Pneumonia</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;No</td><td rowspan="1" colspan="1">164 (91.6%)</td><td rowspan="1" colspan="1">1 (Reference)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x02002;Yes</td><td rowspan="1" colspan="1">15 (8.4%)</td><td rowspan="1" colspan="1">1.425 [0.719&#x02013;2.824]</td><td rowspan="1" colspan="1">0.310</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-2fn"><p><bold>Notes:</bold></p></fn><fn id="table-2fn1" fn-type="other"><p>Characteristics with <italic>P</italic> &#x0003c; 0.3 in the univariate analysis were further screened in the multivariate analysis.</p></fn><fn id="table-2fn2" fn-type="other"><p>HR, hazard ratio; CI, confidence interval; TNM stage, tumor-node-metastasis stage; T stage, stage of tumor invasion; N stage, stage of regional lymph node invasion.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table-3" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/table-3</object-id><label>Table 3</label><caption><title>Correlation of collagen family gene expression and clinicopathological characteristics of ESCC patients from the TCGA dataset.</title></caption><alternatives><graphic xlink:href="peerj-07-7705-g008"/><table frame="hsides" rules="groups" content-type="text"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Ag &#x02265; 60</th><th rowspan="1" colspan="1">Sex (Female)</th><th rowspan="1" colspan="1">TNM stage III/IV</th><th rowspan="1" colspan="1">N stage (N1 + N2)</th><th rowspan="1" colspan="1">Tumor grade (G3)</th><th rowspan="1" colspan="1">Tumor location (Lower)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">COL1A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.222<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.048</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL1A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.222<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.048</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL2A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL3A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;2.225<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.045</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL5A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL5A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.231<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.039</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL5A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.229<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.041</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL7A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.226<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.046</sup></td><td rowspan="1" colspan="1">&#x02212;0.226<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.046</sup></td></tr><tr><td rowspan="1" colspan="1">COL8A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL8A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL9A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL9A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL9A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.318<xref ref-type="fn" rid="table-3fn3">**</xref><sup>0.004</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL10A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL11A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL11A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL12A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.288<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.010</sup></td></tr><tr><td rowspan="1" colspan="1">COL13A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL14A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL15A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL16A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.280<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.013</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.280<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.013</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL17A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.299<xref ref-type="fn" rid="table-3fn3">**</xref><sup>0.008</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.299<xref ref-type="fn" rid="table-3fn3">**</xref><sup>0.008</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL18A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL19A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.367<xref ref-type="fn" rid="table-3fn3">**</xref><sup>0.00</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL20A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL21A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.243<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.030</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL22A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL23A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL24A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL25A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL26A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL27A1</td><td rowspan="1" colspan="1">&#x02212;0.245<xref ref-type="fn" rid="table-3fn2">*</xref><sup>0.02</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL28A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-3fn"><p><bold>Notes:</bold></p></fn><fn id="table-3fn1" fn-type="other"><p>Superscripts of the correlation coefficients represent <italic>P</italic>-values.</p></fn><fn id="table-3fn2" fn-type="other"><label>*</label><p>Correlation with <italic>P</italic> &#x0003c; 0.05.</p></fn><fn id="table-3fn3" fn-type="other"><label>**</label><p>Correlation with <italic>P</italic> &#x0003c; 0.01.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table-4" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/table-4</object-id><label>Table 4</label><caption><title>Correlation of collagen family gene expression and clinicopathological characteristics of ESCC patients in GEO.</title></caption><alternatives><graphic xlink:href="peerj-07-7705-g009"/><table frame="hsides" rules="groups" content-type="text"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Gene</th><th rowspan="1" colspan="1">Age &#x02265; 60</th><th rowspan="1" colspan="1">Sex (Female)</th><th rowspan="1" colspan="1">TNM stage III + IV</th><th rowspan="1" colspan="1">N stage (N1 + N2)</th><th rowspan="1" colspan="1">Tumor grade (G3)</th><th rowspan="1" colspan="1">Tumor location (Lower)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">COL1A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL1A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL2A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL3A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.149<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.046</sup></td><td rowspan="1" colspan="1">&#x02212;0.162<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.030</sup></td></tr><tr><td rowspan="1" colspan="1">COL4A4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.168<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.024</sup></td></tr><tr><td rowspan="1" colspan="1">COL4A5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL4A6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL5A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL5A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL5A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.167<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.026</sup></td></tr><tr><td rowspan="1" colspan="1">COL6A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.173<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.020</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL6A6</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL7A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL8A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.188<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.012</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL8A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL9A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL9A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.175<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.019</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL9A3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.162<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.030</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL10A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.151<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.044</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL11A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL11A2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL12A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL13A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL14A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL15A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL16A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL17A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL18A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL19A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.174<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.020</sup></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL20A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL21A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.163<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.029</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL22A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL23A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL24A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL25A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.147<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.049</sup></td></tr><tr><td rowspan="1" colspan="1">COL26A1</td><td rowspan="1" colspan="1">0.174<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.020</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.206<xref ref-type="fn" rid="table-4fn3">**</xref><sup>0.006</sup></td></tr><tr><td rowspan="1" colspan="1">COL27A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x02212;0.174<xref ref-type="fn" rid="table-4fn2">*</xref><sup>0.020</sup></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">COL28A1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-4fn"><p><bold>Notes:</bold></p></fn><fn id="table-4fn1" fn-type="other"><p>Superscripts of the correlation coefficients represent <italic>P</italic>-values.</p></fn><fn id="table-4fn2" fn-type="other"><label>*</label><p>Correlation with <italic>P</italic> &#x0003c; 0.05.</p></fn><fn id="table-4fn3" fn-type="other"><label>**</label><p>Correlation with <italic>P</italic> &#x0003c; 0.01.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Identification of DEGs of collagen family in ESCC tissues</title><p>Differential expression analysis showed that more than 2/3 of the 44 collagen family genes were up-regulated in tumor tissues in both TCGA and GEO (<xref ref-type="supplementary-material" rid="supp-1">Tables S1</xref> and <xref ref-type="supplementary-material" rid="supp-2">S2</xref>). A total of 22 members in TCGA and 35 members in GEO were identified as DEGs, and their expression patterns were shown by heatmaps (<xref ref-type="fig" rid="fig-1">Figs. 1A</xref> and <xref ref-type="fig" rid="fig-1">1B</xref>). Then the Venn diagram demonstrated that there were 22 mutual DEGs between the two datasets (<xref ref-type="fig" rid="fig-1">Fig. 1C</xref>), which meant the DEGs observed in TCGA were also DEGs in GEO. Obviously from the heatmaps, COL1A1, COL10A1 and COL11A1 ranked in the top five among the up-regulated DEGs in both datasets (<xref ref-type="fig" rid="fig-1">Figs. 1D</xref>&#x02013;<xref ref-type="fig" rid="fig-1">1I</xref>), further presented by boxplots. Likewise, COL4A4, COL6A5 and COL14A1 were the most down-regulated candidates (<xref ref-type="fig" rid="fig-1">Figs. 1J</xref>&#x02013;<xref ref-type="fig" rid="fig-1">1O</xref>).</p><fig id="fig-1" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/fig-1</object-id><label>Figure 1</label><caption><title>Differential expression analysis of collagen family genes between ESCC and normal tissues.</title><p>(A) and (B) Heatmaps of the DEGs in TCGA and GEO in descending order of logFC. The red and blue colors represent high and low expression, respectively. *<italic>P</italic> &#x0003c; 0.05; **<italic>P</italic> &#x0003c; 0.01; ***<italic>P</italic> &#x0003c; 0.001. (C) The Venn diagram showing the overlapped DEGs between the two datasets. (D&#x02013;I) Boxplots of three representative up-regulated genes, COL1A1, COL10A1 and COL11A1 in TCGA and GEO. (J&#x02013;O) Boxplots of three representative down-regulated genes, COL4A4, COL6A5 and COL14A1 in TCGA and GEO. DEG, differentially expressed gene; FC, fold change.</p></caption><graphic xlink:href="peerj-07-7705-g001"/></fig></sec><sec><title>Survival analysis of collagen family genes in ESCC patients</title><p>HRs and <italic>P</italic>-values of the 22 DEGs were calculated and shown by heatmaps (<xref ref-type="fig" rid="fig-2">Figs. 2A</xref> and <xref ref-type="fig" rid="fig-2">2B</xref>). Among them, HRs of COL6A5 and COL18A1 were the lowest and highest, respectively. Survival curves of the DEGs were plotted according to the Kaplan&#x02013;Meier method. Consistently, COL6A5 and COL18A1 were the two genes most relevant to the overall survival of ESCC patients. Patients with lower COL6A5 expression exhibited poorer overall survival (<italic>P</italic> = 0.008 in TCGA, <xref ref-type="fig" rid="fig-2">Fig. 2C</xref>; <italic>P</italic> = 0.060 in GEO, <xref ref-type="fig" rid="fig-2">Fig. 2D</xref>). By contrast, patients with higher COL18A1 expression had worse overall survival (<italic>P</italic> = 0.393 in TCGA, <xref ref-type="fig" rid="fig-2">Fig. 2E</xref>; <italic>P</italic> = 0.009 in GEO, <xref ref-type="fig" rid="fig-2">Fig. 2F</xref>). These results suggested that COL6A5 and COL18A1 are tightly associated with the prognosis of ESCC.</p><fig id="fig-2" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/fig-2</object-id><label>Figure 2</label><caption><title>Survival analysis of the DEGs of collagen family in ESCC patients.</title><p>(A) and (B) HRs and <italic>P</italic>-values of the DEGs related to overall survival in ascending order of HR in TCGA and GEO. (C) and (D) Kaplan&#x02013;Meier survival curves of COL6A5 in TCGA and GEO. (E) and (F) Kaplan&#x02013;Meier survival curves of COL18A1 in TCGA and GEO. DEG, differentially expressed gene; HR, hazard ratio.</p></caption><graphic xlink:href="peerj-07-7705-g002"/></fig></sec><sec><title>DEGs-based prediction models to predict the prognosis of ESCC patients</title><p>Receiver operating characteristic curves have been extensively used to evaluate the predictive effect of one or more genes. The AUC value represents predictive accuracy and usually makes sense when it exceeds 0.60 (<xref rid="ref-29" ref-type="bibr">L&#x000fc;demann et al., 2006</xref>; <xref rid="ref-32" ref-type="bibr">Metz, 1978</xref>; <xref rid="ref-35" ref-type="bibr">Obuchowski, 2003</xref>). ROC curves of COL6A5 and COL18A1 indicated that good predictive performance could only be attained by COL6A5 in TCGA (AUC = 0.679, <xref ref-type="supplementary-material" rid="supp-9">Fig. S1A</xref>), while COL18A1 had no predictive ability (<xref ref-type="supplementary-material" rid="supp-9">Figs. S1C</xref> and <xref ref-type="supplementary-material" rid="supp-9">S1D</xref>), suggesting that a single gene is not suitable for survival prediction of ESCC patients. Therefore, we established multi-gene prediction models based on expression levels of the DEGs to assess the joint effect of selected collagen genes on patient survival. There were seven genes in TCGA and nine genes in GEO finally included to form the models, respectively, and risk scores of the patients were calculated according to the below formulas:
<disp-formula id="eqn-2"><label>(2)</label><alternatives><graphic xlink:href="peerj-07-7705-e002.jpg" mimetype="image" mime-subtype="png" position="float" orientation="portrait"/><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\eqalign{ {\rm{Risk\,score}}\left( {{\rm{TCGA}}} \right) =\,&#x00026; \left( {{\rm{1}}{\rm{.528*COL1A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) + \left( {{\rm{0}}{\rm{.265*COL4A}}{{\rm{4}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( { - {\rm{0}}{\rm{.539*COL6A}}{{\rm{5}}_{_{{\rm{Exp}}}}}} \right) + \left( { - {\rm{0}}{\rm{.638*COL11A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( { - {\rm{1}}{\rm{.193*COL12A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) + \left( { - {\rm{0}}{\rm{.244*COL19A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( {{\rm{0}}{\rm{.417*COL24A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr} $$\end{document}</tex-math><mml:math id="mml-eqn-2"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mtext>Risk&#x000a0;score</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mtext>TCGA</mml:mtext></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1.528</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>1</mml:mn><mml:mtext>A</mml:mtext><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext>&#x02009;</mml:mtext><mml:mo>+</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0.265</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>4</mml:mn><mml:mtext>A</mml:mtext><mml:msub><mml:mn>4</mml:mn><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;</mml:mtext><mml:mo>+</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>0.539</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>6</mml:mn><mml:mtext>A</mml:mtext><mml:msub><mml:mn>5</mml:mn><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext>&#x02009;</mml:mtext><mml:mo>+</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>0.638</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>11</mml:mn><mml:mtext>A</mml:mtext><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;</mml:mtext><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1.193</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>12</mml:mn><mml:mtext>A</mml:mtext><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext>&#x02009;</mml:mtext><mml:mo>+</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>0.244</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>19</mml:mn><mml:mtext>A</mml:mtext><mml:mn>1</mml:mn><mml:msub><mml:malignmark/><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mtext>&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;</mml:mtext><mml:mo>+</mml:mo><mml:mtext>&#x02009;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0.417</mml:mn><mml:mtext>&#x02009;</mml:mtext><mml:mo>*</mml:mo><mml:mtext>&#x02009;COL</mml:mtext><mml:mn>24</mml:mn><mml:mtext>A</mml:mtext><mml:msub><mml:mn>1</mml:mn><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></alternatives></disp-formula>
<disp-formula id="eqn-3"><label>(3)</label><alternatives><graphic xlink:href="peerj-07-7705-e003.jpg" mimetype="image" mime-subtype="png" position="float" orientation="portrait"/><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\eqalign{ {\rm{Risk\,score}}\left( {{\rm{GEO}}} \right) =\,&#x00026; \left( {{\rm{7}}{\rm{.700*COL1A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) + \left( { - {\rm{8}}{\rm{.800*COL1A}}{{\rm{2}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( { - {\rm{5}}{\rm{.800*COL3A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) + \left( {{\rm{6}}{\rm{.320* COL5A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( { - {\rm{0}}{\rm{.708*COL6A}}{{\rm{5}}_{_{{\rm{Exp}}}}}} \right) + \left( { - {\rm{0}}{\rm{.790*COL11A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( {{\rm{1}}{\rm{.990*COL14A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) + \left( {{\rm{1}}{\rm{.300*COL22A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr &#x00026;+ \left( {{\rm{2}}{\rm{.400*COL24A}}{{\rm{1}}_{_{{\rm{Exp}}}}}} \right) \cr} $$\end{document}</tex-math><mml:math id="mml-eqn-3"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mtext>Risk&#x000a0;score&#x000a0;(GEO)&#x000a0;=&#x000a0;(7</mml:mtext><mml:msub><mml:mtext>.700&#x000a0;*&#x000a0;COL1A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)&#x000a0;+&#x000a0;(-8</mml:mtext><mml:msub><mml:mtext>.800&#x000a0;*&#x000a0;COL1A2</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)&#x000a0;</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;+&#x000a0;(-5</mml:mtext><mml:msub><mml:mtext>.800&#x000a0;*&#x000a0;COL3A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)&#x000a0;+&#x000a0;(6</mml:mtext><mml:msub><mml:mtext>.320&#x000a0;*&#x000a0;COL5A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;+&#x000a0;(-0</mml:mtext><mml:msub><mml:mtext>.708&#x000a0;*&#x000a0;COL6A5</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)&#x000a0;+&#x000a0;(-0</mml:mtext><mml:msub><mml:mtext>.790&#x000a0;*&#x000a0;COL11A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;+&#x000a0;(1</mml:mtext><mml:msub><mml:mtext>.990&#x000a0;*&#x000a0;COL14A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)&#x000a0;+&#x000a0;(1</mml:mtext><mml:msub><mml:mtext>.300&#x000a0;*&#x000a0;COL22A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>)</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;+&#x000a0;(2</mml:mtext><mml:msub><mml:mtext>.400&#x000a0;*&#x000a0;COL24A1</mml:mtext><mml:mrow><mml:mtext>Exp</mml:mtext></mml:mrow></mml:msub><mml:mtext>).</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula></p><p>For instance, the positive coefficient for COL1A1 suggests that higher expression of COL1A1 was associated with worse survival. The negative value allocated to COL6A5 means that higher expression of COL6A5 was related to prolonged survival, in agreement with the survival analysis (<xref ref-type="fig" rid="fig-2">Fig. 2</xref>). Notably, AUCs on the ROC curves of the DEGs-based models in TCGA and GEO reached 0.86 and 0.68, respectively (<xref ref-type="fig" rid="fig-3">Figs. 3A</xref> and <xref ref-type="fig" rid="fig-3">3C</xref>), which were higher than those of the prediction models based on TNM staging in the two datasets with AUCs of 0.625 and 0.646, respectively (<xref ref-type="fig" rid="fig-3">Figs. 3E</xref> and <xref ref-type="fig" rid="fig-3">3G</xref>). The TNM staging system is a generally recognized standard for classifying the spreading extent of cancer (<xref rid="ref-9" ref-type="bibr">D&#x02019;Journo, 2018</xref>) and is commonly used to predict prognosis of cancer in clinical application. The prediction models, respectively, based on T-stage and N-stage were also examined but the AUCs were all less than 0.6 (<xref ref-type="supplementary-material" rid="supp-10">Fig. S2</xref>). Furthermore, survival curves showed that patients with high risk were significantly correlated with poor survival (<xref ref-type="fig" rid="fig-3">Figs. 3B</xref>, <xref ref-type="fig" rid="fig-3">3D</xref>, <xref ref-type="fig" rid="fig-3">3F</xref> and <xref ref-type="fig" rid="fig-3">3H</xref>). The 7-gene model in TCGA with true positive rate of 86% was more accurate than that of the TNM staging-based model, whereas predictive accuracy of the 9-gene model in GEO exhibited no difference. Therefore, the model in TCGA was used for our further studies. Finally, a heatmap was plotted to show the expression patterns of the seven genes in TCGA between high-risk and low-risk groups (<xref ref-type="fig" rid="fig-3">Fig. 3I</xref>). The risk score distribution was exhibited in ascending order, and patients were divided into high- and low-risk groups by the median point (<xref ref-type="fig" rid="fig-3">Fig. 3J</xref>). Overall, it can be seen that patients with high risk score had higher mortality rates and shorter survival time than those with low risk score (<xref ref-type="fig" rid="fig-3">Fig. 3K</xref>). Taken together, above results indicated that the 7-gene model could be more accurate to predict patient survival.</p><fig id="fig-3" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/fig-3</object-id><label>Figure 3</label><caption><title>Prediction models to predict the survival of ESCC patients.</title><p>(A&#x02013;D) ROC and survival curves of the models based on expression of 7 and 9 collagen DEGs, respectively, in TCGA and GEO. (E&#x02013;H) ROC and survival curves of the models according to TNM staging in TCGA and GEO. (I) A heatmap showing the expression patterns of the seven genes driving the prediction model in TCGA. (J) Risk score distribution of the patients in ascending order and divided into low-risk (green) and high-risk (red) in TCGA. (K) Survival time and status of the patients in order of increasing risk scores in TCGA. The red and green dots represent dead and alive, respectively. ROC, receiver operating characteristic; AUC, area under curve; DEG, differentially expressed gene; COL, collagen; TNM, tumor-node-metastasis.</p></caption><graphic xlink:href="peerj-07-7705-g003"/></fig></sec><sec><title>Pathway analysis of collagen family genes</title><p>Gene sets enrichment analysis results showed that most of the gene sets were up-regulated in the high-risk group, and the top 20 enriched gene sets were given in <xref ref-type="supplementary-material" rid="supp-3">Tables S3</xref>&#x02013;<xref ref-type="supplementary-material" rid="supp-8">S8</xref>. The gene sets that were closely associated with tumorigenesis were shown in <xref ref-type="fig" rid="fig-4">Fig. 4</xref>. For instance, gene sets of PDGF, RB/P107, AKT/MTOR and p53 were significantly up-regulated according to Oncogenic Signatures Gene Sets (<xref ref-type="fig" rid="fig-4">Figs. 4A</xref>&#x02013;<xref ref-type="fig" rid="fig-4">4F</xref>). Based on Hallmark Gene Sets, the enriched gene sets included p53 pathway, oxidative phosphorylation, apoptosis, mitotic spindle, G2/M checkpoint and notch signaling (<xref ref-type="fig" rid="fig-4">Figs. 4G</xref>&#x02013;<xref ref-type="fig" rid="fig-4">4L</xref>). Using KEGG Gene Sets as reference, the high-risk group was tightly correlated with oxidative phosphorylation, renal cell carcinoma, bladder cancer, small cell lung cancer, adherens junction and cell cycle (<xref ref-type="fig" rid="fig-4">Figs. 4M</xref>&#x02013;<xref ref-type="fig" rid="fig-4">4R</xref>).</p><fig id="fig-4" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/fig-4</object-id><label>Figure 4</label><caption><title>GSEA results based on patient risk scores calculated by the prediction models in TCGA and GEO.</title><p>(A&#x02013;F) Representative enriched gene sets according to Oncogenic Signatures Gene Sets. (G&#x02013;L) Representative enriched gene sets according to Hallmark Gene Sets. (M&#x02013;R) Representative enriched gene sets according to KEGG Gene Sets. GSEA, gene sets enrichment analysis. NES, normalized enrichment score.</p></caption><graphic xlink:href="peerj-07-7705-g004"/></fig></sec><sec><title>Co-expression network analysis</title><p>WGCNA was performed to find out the genes that were co-expressed with collagen family genes in ESCC tissues. Risk-score-based DEGs that were differentially expressed between high- and low-risk groups were determined and presented by the volcano plot (<xref ref-type="supplementary-material" rid="supp-11">Fig. S3</xref>). The co-expression network of collagen genes and the risk-score-based DEGs were given in several modules (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>). Collagen family genes were displayed as red nodes, and the genes included in the 7-gene prediction model in TCGA were marked as bigger red nodes. The blue nodes represented the co-expressed genes. Another network was drawn to show the association between collagen family genes and seven representative enriched gene sets (PDGF, RB/p107, PI3K/Akt/mTOR pathway, p53 pathway, oxidative phosphorylation, apoptosis and cell cycle) from the GSEA results (<xref ref-type="supplementary-material" rid="supp-12">Fig. S4</xref>). The red nodes were the collagen family genes with close connections to those gene sets. A big blue circle represented a gene set and the blue nodes were genes included in each set. Genes closer to the center were more tightly associated with the collagen genes.</p><fig id="fig-5" orientation="portrait" position="float"><object-id pub-id-type="doi">10.7717/peerj.7705/fig-5</object-id><label>Figure 5</label><caption><title>Co-expression network of collagen family genes.</title><p>Visualization of the co-expression between collagen family genes and the risk-scores-based DEGs. The red nodes are collagen family genes, and the bigger ones are the genes included in the 7-gene prediction model in TCGA. The blue nodes are the co-expressed genes. DEG, differentially expressed gene.</p></caption><graphic xlink:href="peerj-07-7705-g005"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Although extensive research efforts have been focused on this field in past decades, efficient detection methods for early ESCC and accurate prediction against complicated ESCC patients still remain an open issue. Recently, studies have found that the expression of certain genes, such as MCT4, ZNF750, Gli1, etc. was highly related to the occurrence and development of ESCC, and they might be applied as ideal biomarkers for ESCC (<xref rid="ref-6" ref-type="bibr">Cheng et al., 2018</xref>; <xref rid="ref-34" ref-type="bibr">Nambara et al., 2017</xref>; <xref rid="ref-59" ref-type="bibr">Yang et al., 2017</xref>; <xref rid="ref-63" ref-type="bibr">Zhang et al., 2018b</xref>). In addition, the aberrant expression of a few collagen family genes has also been reported to be significantly associated with the prognosis of ESCC patients. However, most works only focused on single or limited genes, and the predictive ability was barely satisfactory. Herein, we provided a more systematic analysis of the whole collagen family gene expression to evaluate the potential roles and clinical significance of collagen genes in ESCC.</p><p>We found that most of the collagen genes were up-regulated in ESCC tissues when compared to normal controls, half of which were identified as DEGs (<xref ref-type="fig" rid="fig-1">Figs. 1A</xref> and <xref ref-type="fig" rid="fig-1">1B</xref>). Among them, the expression of COL1A1, COL10A1 and COL11A1 was particularly higher, and that of COL4A4, COL6A5 and COL14A1 was especially lower in tumor tissues, indicating their possible roles as diagnostic markers for ESCC. Consistently, several studies have shown that COL1A1, COL10A1 and COL11A1 were notably overexpressed in ESCC compared to normal tissues (<xref rid="ref-11" ref-type="bibr">Fang et al., 2019</xref>; <xref rid="ref-16" ref-type="bibr">He et al., 2017</xref>; <xref rid="ref-18" ref-type="bibr">Karagoz et al., 2016</xref>; <xref rid="ref-47" ref-type="bibr">Senthebane et al., 2018</xref>; <xref rid="ref-64" ref-type="bibr">Zhang et al., 2018a</xref>). Also, COL4A4 was also found to be down-regulated in esophageal tumor tissues (<xref rid="ref-5" ref-type="bibr">Chattopadhyay et al., 2009</xref>). Additionally, among the DEGs, COL7A1 was observed to be up-regulated in ESCC tissues (<xref rid="ref-19" ref-type="bibr">Kita et al., 2009</xref>). In our works, COL6A5, COL14A1 and some other collagen genes were reported to be significantly up- or down-regulated in ESCC tissues for the first time.</p><p>In the survival analysis, COL6A5 and COL18A1 were validated to be significantly related to overall survival of ESCC patients. Previous studies demonstrated that the COL6A5 expression was significantly associated with depressed behavior and atopic dermatitis (<xref rid="ref-50" ref-type="bibr">S&#x000f6;derh&#x000e4;ll et al., 2007</xref>; <xref rid="ref-61" ref-type="bibr">Zhan et al., 2017</xref>), but no articles manifested its correlation with cancer. In addition, COL18A1 has been proved to be a promising biomarker for ovarian cancer and was possibly involved in the progression of bladder cancer (<xref rid="ref-12" ref-type="bibr">Fang et al., 2013</xref>; <xref rid="ref-40" ref-type="bibr">Peters et al., 2005</xref>). In this study, ESCC patients with low COL6A5 expression or high COL18A1 expression showed poor overall survival (<xref ref-type="fig" rid="fig-2">Figs. 2C</xref>&#x02013;<xref ref-type="fig" rid="fig-2">2F</xref>), implying the expression of COL6A5 or COL18A1 as a potential indicator for the prognosis of ESCC patients. Moreover, the variations that affect the expression of COL6A5 and COL18A1 possibly have effects on the progression of ESCC. Activating COL6A5 or inhibiting COL18A1 might improve the therapeutic efficiency and the life-span of ESCC patients.</p><p>Because the expression of one gene is usually influenced by various factors, ideal effect may not be attained by using a single gene as a predictor. Indeed, COL6A5 achieved an AUC value over 0.60 only in TCGA (<xref ref-type="supplementary-material" rid="supp-9">Fig. S1</xref>), making the requirement of another more powerful prediction method. Based on the selected collagen DEGs (7 genes in TCGA and 9 genes in GEO, both including COL6A5), we established two new prediction models. Importantly, such DEGs-based models exhibited better predictive ability than conventional prognostic models according to TNM staging. The 7-gene model in TCGA had especially higher predictive accuracy of 86%. One possible reason was that the RNA sequencing technology applied to TCGA was more accurate than the gene chip technology used in GEO. In summary, this 7-gene prediction model is greatly promising to predict the prognosis of ESCC patients and help determine next therapeutic regimens.</p><p>Furthermore, GSEA was used to identify significantly enriched gene sets and potentially relevant pathways (<xref ref-type="fig" rid="fig-4">Fig. 4</xref>). The results showed that based on Oncogenic Signatures Gene Sets, gene sets of PDGF, RB/P107 and AKT/MTOR were significantly enriched in the high-risk group. It has been reported that PDGF receptor-beta increased the expression of COL1A2 through Akt/mTORC1 signaling pathway (<xref rid="ref-8" ref-type="bibr">Das et al., 2017</xref>). According to Oncogenic Signatures Gene Sets and Hallmark Gene Sets, the high-risk group was significantly related to p53 and p53 pathway, which suggested that collagen genes might be highly associated with the p53 or its related pathway in ESCC. Earlier studies proved that enhanced expression of ectopic p53 in dermal fibroblasts inhibited basal and TGF-beta-stimulated collagen gene expression, and the absence of cellular p53 was correlated with increased transcriptional activity of the Type I collagen gene (COL1A2) and collagen synthesis (<xref rid="ref-13" ref-type="bibr">Ghosh, Bhattacharyya &#x00026; Varga, 2004</xref>). Moreover, the type IV collagen expression was inversely related to p53 in malignant tumors (<xref rid="ref-1" ref-type="bibr">Bar et al., 2004</xref>). Oxidative phosphorylation related genes were found to be up-regulated in the high-risk group by both Hallmark Gene Sets and KEGG Gene Sets. Indeed, some reports demonstrated that oxidative phosphorylation signature occurred when collagen density was decreased, and the change of collagen density microenvironment regulated the metabolism of cancer cells (<xref rid="ref-30" ref-type="bibr">Mah et al., 2018</xref>; <xref rid="ref-33" ref-type="bibr">Morris et al., 2016</xref>). As for apoptosis, an earlier study has shown that Type IV collagen could stimulate cancer cell proliferation, migration and inhibit apoptosis (<xref rid="ref-36" ref-type="bibr">&#x000d6;hlund et al., 2013</xref>). Additionally, the gene sets of mitotic spindle, G2/M checkpoint and cell cycle were enriched in the high-risk group as well, implying that collagen might regulate the cell cycle of ESCC cells. Furthermore, it was indicated that the high-risk group was markedly associated with renal cell carcinoma, bladder cancer and small cell lung cancer. These results were consistent with previous studies that collagen gene expression was correlated with the poor prognosis of those cancers (<xref rid="ref-20" ref-type="bibr">Koskimaki et al., 2010</xref>; <xref rid="ref-55" ref-type="bibr">Wan et al., 2015</xref>; <xref rid="ref-58" ref-type="bibr">Xu et al., 2017</xref>; <xref rid="ref-60" ref-type="bibr">Zeng et al., 2018</xref>).</p><p>As shown by the co-expression network (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>), a few collagen family genes such as COL1A1, COL11A1, COL6A6 and COL19A1, were co-expressed with NETO1, NEUROD2 and NRG3, which are the genes involved in neural functions. These findings could be verified by earlier articles to some extent (<xref rid="ref-31" ref-type="bibr">McCarthy &#x00026; Hay, 1991</xref>; <xref rid="ref-38" ref-type="bibr">Perris et al., 1993a</xref>, <xref rid="ref-39" ref-type="bibr">1993b</xref>). COL11A1 was also observed to be co-expressed with tumor suppressor candidate 7 (TUSC7), further validating the possible role of COL11A1 in the occurrence of ESCC. Beyond that, some potassium channel related genes (KCNA2, KCNE1B, KCNH1, KCNJ4 and KCNK4) were co-expressed with collagen genes in a way, revealing that collagen genes might be correlated with the regulation of potassium channels in ESCC. As for the two potential prognostic biomarkers, COL18A1 only showed close relations with collagen family members, while COL6A5 was associated with two other genes in this network, ROBO2 and MIR548A3. ROBO2 has been identified as a candidate tumor suppressor (<xref rid="ref-54" ref-type="bibr">Trifonov et al., 2013</xref>), and the alteration of its expression might play a role in malignant tumors of digestive tract including gastric and colorectal cancers (<xref rid="ref-17" ref-type="bibr">Je et al., 2013</xref>).</p><p>Apart from what is aforementioned, there are still some limitations of this research. For instance, the prediction model was comprised of several genes, making it difficult to conduct cellular experiments by targeting a single gene to confirm its predictive effect. Aside from it, the characteristics of patient samples, as well as the methodology utilized in TCGA, were somewhat different from that in GEO, which may explain the different results coming from the two datasets. For example, TCGA uses the RNA sequence technology while GEO applies the gene chip technology to detect gene expression of patient tissues. Besides, TCGA mainly collected data from white people, whereas the majority of patients in GEO (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53625">GSE53625</uri>) were Asian. Therefore, there was no a single gene that exhibited significant <italic>P</italic>-values in both datasets in the survival analysis, and the selected genes driving the prediction model in one dataset were not completely identical to those in another dataset. Further validation of these outcomes requires more clinical information and biological experiments in the future.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In summary, this study identified 22 collagen family genes that were significantly expressed higher or lower in ESCC compared to normal tissues. Among them, COL1A1, COL10A1, COL11A1, COL4A4, COL6A5 and COL14A1 were the most distinct ones and possessed the potential in ESCC diagnosis. Besides, COL6A5 and COL18A1 showed strong correlations with overall survival of ESCC patients and might be robust prognostic biomarkers for ESCC. Furthermore, we established a 7-gene prediction model with high performance to predict the prognosis of ESCC patients. In terms of the underlying mechanism, collagen genes might be associated with PI3K/Akt/mTOR pathway, p53 pathway, oxidative phosphorylation, apoptosis and cell cycle during the progression of ESCC. Our works may further benefit the diagnosis, prognosis and treatments for ESCC patients.</p></sec><sec sec-type="supplementary-material" id="supplemental-information"><title>Supplemental Information</title><supplementary-material content-type="local-data" id="supp-1"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-1</object-id><label>Supplemental Information 1</label><caption><title>The results of differential expression analysis of collagen family genes in TCGA.</title><p>A total of 44 collagen family genes are listed in descending order of logFC. Genes with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.05 were considered as differentially expressed genes (DEGs). logFC, log2 (fold change); logCPM, log2 (counts per million); FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s001.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-2"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-2</object-id><label>Supplemental Information 2</label><caption><title>The results of differential expression analysis of collagen family genes in GEO.</title><p>A total of 44 collagen family genes are listed in descending order of logFC. Genes with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.05 were considered as differentially expressed genes (DEGs). logFC, log2 (fold change); AveExpr, Average expression; <italic>t</italic>, <italic>t</italic>-statistic; adj.P.Val, adjusted <italic>P</italic>-value; B, B-statistic.</p></caption><media xlink:href="peerj-07-7705-s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-3"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-3</object-id><label>Supplemental Information 3</label><caption><title>The top 20 enriched gene sets according to Oncogenic Signatures Gene Sets in TCGA.</title><p>Oncogenic Signatures Gene sets are signatures of cellular pathways usually dis-regulated in cancer. The top 20 gene sets are listed in descending order of NES, which reflects the degree to which a gene set was overrepresented in the groups. Gene sets with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered to be significant. ES, enrichment score; NES, normalized enrichment score; NOM p-val, nominal <italic>P</italic>-value; FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-4"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-4</object-id><label>Supplemental Information 4</label><caption><title>The top 20 enriched gene sets according to Oncogenic Signatures Gene Sets in GEO.</title><p>Oncogenic Signatures Gene sets are signatures of cellular pathways usually dis-regulated in cancer. The top 20 gene sets are listed in descending order of NES, which reflects the degree to which a gene set was overrepresented in the groups. Gene sets with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered to be significant. ES, enrichment score; NES, normalized enrichment score; NOM p-val, nominal <italic>P</italic>-value; FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s004.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-5"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-5</object-id><label>Supplemental Information 5</label><caption><title>The top 20 enriched gene sets according to Hallmark Gene Sets in TCGA.</title><p>Hallmark Gene Sets summarize and represent specific well-defined biological states or processes and display coherent expression. The top 20 gene sets are listed in descending order of NES, which reflects the degree to which a gene set was overrepresented in the groups. Gene sets with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered to be significant. ES, enrichment score; NES, normalized enrichment score; NOM p-val, nominal <italic>P</italic>-value; FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s005.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-6"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-6</object-id><label>Supplemental Information 6</label><caption><title>The top 20 enriched gene sets according to Hallmark Gene Sets in GEO.</title><p>Hallmark Gene Sets summarize and represent specific well-defined biological states or processes and display coherent expression. The top 20 gene sets are listed in descending order of NES, which reflects the degree to which a gene set was overrepresented in the groups. Gene sets with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered to be significant. ES, enrichment score; NES, normalized enrichment score; NOM p-val, nominal <italic>P</italic>-value; FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s006.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-7"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-7</object-id><label>Supplemental Information 7</label><caption><title>The top 20 enriched gene sets according to KEGG Curated Gene Sets in TCGA.</title><p>KEGG Gene Sets are derived from the KEGG pathway database. The top 20 gene sets are listed in descending order of NES, which reflects the degree to which a gene set was overrepresented in the groups. Gene sets with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered to be significant. ES, enrichment score; NES, normalized enrichment score; NOM p-val, nominal <italic>P</italic>-value; FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s007.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-8"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-8</object-id><label>Supplemental Information 8</label><caption><title>The top 20 enriched gene sets according to KEGG Curated Gene Sets in GEO.</title><p>KEGG Gene Sets are derived from the KEGG pathway database. The top 20 gene sets are listed in descending order of NES, which reflects the degree to which a gene set was overrepresented in the groups. Gene sets with <italic>P</italic> &#x0003c; 0.05 and FDR &#x0003c; 0.25 were considered to be significant. ES, enrichment score; NES, normalized enrichment score; NOM p-val, nominal <italic>P</italic>-value; FDR, false discovery rate.</p></caption><media xlink:href="peerj-07-7705-s008.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-9"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-9</object-id><label>Supplemental Information 9</label><caption><title>Single-gene prediction models based on the gene expression of COL6A5 and COL18A1 in TCGA and GEO datasets.</title><p>(A) and (B) ROC curves of COL6A5 in the two datasets. (C) and (D) ROC curves of COL18A1 in the two datasets.</p></caption><media xlink:href="peerj-07-7705-s009.png"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-10"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-10</object-id><label>Supplemental Information 10</label><caption><title>Prediction models according to T-stage and N-stage of the patients in TCGA and GEO datasets.</title><p>(A) and (B) ROC curves of T-stage in the two datasets. (C) and (D) ROC curves of N-stage in the two datasets.</p></caption><media xlink:href="peerj-07-7705-s010.png"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-11"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-11</object-id><label>Supplemental Information 11</label><caption><title>Volcano plot showing the DEGs that were differentially expressed between high- and low-risk groups based on the risk scores calculated by the 7-gene prediction model in TCGA.</title><p>Red and green dots indicate up- and down-regulated genes, respectively.</p></caption><media xlink:href="peerj-07-7705-s011.png"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-12"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-12</object-id><label>Supplemental Information 12</label><caption><title>Co-expression network of collagen genes and seven significantly enriched gene sets obtained by GSEA.</title><p>Red nodes are the collagen family genes closely correlated with those gene sets. A big blue circle represented a gene set and the blue nodes were genes included in each gene set.</p></caption><media xlink:href="peerj-07-7705-s012.png"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-13"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-13</object-id><label>Supplemental Information 13</label><caption><title>Gene expression profiles of tumor and normal samples in ESCC patients from the TCGA database.</title></caption><media xlink:href="peerj-07-7705-s013.txt"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="supp-14"><object-id pub-id-type="doi">10.7717/peerj.7705/supp-14</object-id><label>Supplemental Information 14</label><caption><title>Clinical data of ESCC patients from the TCGA database.</title></caption><media xlink:href="peerj-07-7705-s014.txt"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><sec sec-type="additional-information"><title>Additional Information and Declarations</title><fn-group content-type="competing-interests"><title>Competing Interests</title><fn fn-type="COI-statement" id="conflict-1"><p>The authors declare that they have no competing interests.</p></fn></fn-group><fn-group content-type="author-contributions"><title>Author Contributions</title><fn fn-type="con" id="contribution-1"><p><xref ref-type="contrib" rid="author-1">Jieling Li</xref> performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.</p></fn><fn fn-type="con" id="contribution-2"><p><xref ref-type="contrib" rid="author-2">Xiao Wang</xref> performed the experiments, analyzed the data, prepared figures and/or tables.</p></fn><fn fn-type="con" id="contribution-3"><p><xref ref-type="contrib" rid="author-3">Kai Zheng</xref> authored or reviewed drafts of the paper.</p></fn><fn fn-type="con" id="contribution-4"><p><xref ref-type="contrib" rid="author-4">Ying Liu</xref> prepared figures and/or tables.</p></fn><fn fn-type="con" id="contribution-5"><p><xref ref-type="contrib" rid="author-5">Junjun Li</xref> contributed reagents/materials/analysis tools.</p></fn><fn fn-type="con" id="contribution-6"><p><xref ref-type="contrib" rid="author-6">Shaoqi Wang</xref> collected data.</p></fn><fn fn-type="con" id="contribution-7"><p><xref ref-type="contrib" rid="author-7">Kaisheng Liu</xref> gave advice on this study.</p></fn><fn fn-type="con" id="contribution-8"><p><xref ref-type="contrib" rid="author-8">Xun Song</xref> analyzed the data, authored or reviewed drafts of the paper, approved the final draft, gave advice on the revision of manuscript.</p></fn><fn fn-type="con" id="contribution-9"><p><xref ref-type="contrib" rid="author-9">Nan Li</xref> collected data.</p></fn><fn fn-type="con" id="contribution-10"><p><xref ref-type="contrib" rid="author-10">Shouxia Xie</xref> conceived and designed the experiments, authored or reviewed drafts of the paper, approved the final draft.</p></fn><fn fn-type="con" id="contribution-11"><p><xref ref-type="contrib" rid="author-11">Shaoxiang Wang</xref> conceived and designed the experiments, contributed reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.</p></fn></fn-group><fn-group content-type="other"><title>Data Availability</title><fn id="addinfo-1"><p>The following information was supplied regarding data availability:</p><p>Raw data was downloaded from public databases including TCGA and GEO (<uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53625">GSE53625</uri>). The raw data from TCGA is available as <xref ref-type="supplementary-material" rid="supplemental-information">Supplemental Files</xref>.</p></fn></fn-group></sec><ref-list content-type="authoryear"><title>References</title><ref id="ref-1"><label>Bar et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bar</surname><given-names>JK</given-names></name><name><surname>Grelewski</surname><given-names>P</given-names></name><name><surname>Popiela</surname><given-names>A</given-names></name><name><surname>Noga</surname><given-names>L</given-names></name><name><surname>Rabczy&#x000f1;ski</surname><given-names>J</given-names></name></person-group><article-title>Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity</article-title><source>Gynecologic Oncology</source><year>2004</year><volume>95</volume><issue>1</issue><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2004.06.046</pub-id><pub-id pub-id-type="pmid">15385106</pub-id></element-citation></ref><ref id="ref-2"><label>Beer et al. (2002)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>DG</given-names></name><name><surname>Kardia</surname><given-names>SLR</given-names></name><name><surname>Huang</surname><given-names>C-C</given-names></name><name><surname>Giordano</surname><given-names>TJ</given-names></name><name><surname>Levin</surname><given-names>AM</given-names></name><name><surname>Misek</surname><given-names>DE</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Gharib</surname><given-names>TG</given-names></name><name><surname>Thomas</surname><given-names>DG</given-names></name><name><surname>Lizyness</surname><given-names>ML</given-names></name><name><surname>Kuick</surname><given-names>R</given-names></name><name><surname>Hayasaka</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>JMG</given-names></name><name><surname>Iannettoni</surname><given-names>MD</given-names></name><name><surname>Orringer</surname><given-names>MB</given-names></name><name><surname>Hanash</surname><given-names>S</given-names></name></person-group><article-title>Gene-expression profiles predict survival of patients with lung adenocarcinoma</article-title><source>Nature Medicine</source><year>2002</year><volume>8</volume><issue>8</issue><fpage>816</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1038/nm733</pub-id></element-citation></ref><ref id="ref-3"><label>Bray et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Torre</surname><given-names>LA</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA: A Cancer Journal for Clinicians</source><year>2018</year><volume>68</volume><issue>6</issue><fpage>394</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">30207593</pub-id></element-citation></ref><ref id="ref-4"><label>Chai et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma</article-title><source>Journal of Cancer Research and Clinical Oncology</source><year>2018</year><volume>144</volume><issue>3</issue><fpage>439</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1007/s00432-017-2572-6</pub-id><pub-id pub-id-type="pmid">29299749</pub-id></element-citation></ref><ref id="ref-5"><label>Chattopadhyay et al. (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>I</given-names></name><name><surname>Phukan</surname><given-names>R</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Vasudevan</surname><given-names>M</given-names></name><name><surname>Purkayastha</surname><given-names>J</given-names></name><name><surname>Hewitt</surname><given-names>S</given-names></name><name><surname>Kataki</surname><given-names>A</given-names></name><name><surname>Mahanta</surname><given-names>J</given-names></name><name><surname>Kapur</surname><given-names>S</given-names></name><name><surname>Saxena</surname><given-names>S</given-names></name></person-group><article-title>Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering</article-title><source>Oncology Reports</source><year>2009</year><volume>21</volume><fpage>1135</fpage><lpage>1146</lpage><pub-id pub-id-type="pmid">19360286</pub-id></element-citation></ref><ref id="ref-6"><label>Cheng et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name></person-group><article-title>Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma</article-title><source>Oncology Reports</source><year>2018</year><volume>40</volume><issue>5</issue><fpage>2906</fpage><lpage>2915</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6706</pub-id><pub-id pub-id-type="pmid">30226548</pub-id></element-citation></ref><ref id="ref-7"><label>Codipilly et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codipilly</surname><given-names>DC</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Dawsey</surname><given-names>SM</given-names></name><name><surname>Kisiel</surname><given-names>J</given-names></name><name><surname>Topazian</surname><given-names>M</given-names></name><name><surname>Ahlquist</surname><given-names>D</given-names></name><name><surname>Iyer</surname><given-names>PG</given-names></name></person-group><article-title>Screening for esophageal squamous cell carcinoma: recent advances</article-title><source>Gastrointestinal Endoscopy</source><year>2018</year><volume>88</volume><issue>3</issue><fpage>413</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2018.04.2352</pub-id><pub-id pub-id-type="pmid">29709526</pub-id></element-citation></ref><ref id="ref-8"><label>Das et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>F</given-names></name><name><surname>Ghosh-Choudhury</surname><given-names>N</given-names></name><name><surname>Venkatesan</surname><given-names>B</given-names></name><name><surname>Kasinath</surname><given-names>BS</given-names></name><name><surname>Ghosh Choudhury</surname><given-names>G</given-names></name></person-group><article-title>PDGF receptor-&#x003b2; uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (&#x003b1;2) expression</article-title><source>American Journal of Physiology-Renal Physiology</source><year>2017</year><volume>313</volume><issue>2</issue><fpage>F291</fpage><lpage>F307</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00666.2016</pub-id><pub-id pub-id-type="pmid">28424212</pub-id></element-citation></ref><ref id="ref-9"><label>D&#x02019;Journo (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Journo</surname><given-names>XB</given-names></name></person-group><article-title>Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer</article-title><source>Journal of Thoracic Disease</source><year>2018</year><volume>10</volume><issue>S22</issue><fpage>S2671</fpage><lpage>S2681</lpage><pub-id pub-id-type="doi">10.21037/jtd.2018.03.182</pub-id><pub-id pub-id-type="pmid">30345104</pub-id></element-citation></ref><ref id="ref-10"><label>Fan et al. (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>N-J</given-names></name><name><surname>Gao</surname><given-names>C-F</given-names></name><name><surname>Wang</surname><given-names>C-S</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Lv</surname><given-names>J-J</given-names></name><name><surname>Wang</surname><given-names>X-L</given-names></name><name><surname>Chu</surname><given-names>G-H</given-names></name><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>D-H</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>X-T</given-names></name><name><surname>Meng</surname><given-names>N-L</given-names></name></person-group><article-title>Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method</article-title><source>Journal of Proteomics</source><year>2012</year><volume>75</volume><issue>13</issue><fpage>3977</fpage><lpage>3986</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2012.05.008</pub-id><pub-id pub-id-type="pmid">22583932</pub-id></element-citation></ref><ref id="ref-11"><label>Fang et al. (2019)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Mei</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers</article-title><source>Thoracic Cancer</source><year>2019</year><volume>10</volume><issue>2</issue><fpage>277</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1111/1759-7714.12947</pub-id><pub-id pub-id-type="pmid">30604926</pub-id></element-citation></ref><ref id="ref-12"><label>Fang et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Z-Q</given-names></name><name><surname>Zang</surname><given-names>W-D</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Ye</surname><given-names>B-W</given-names></name><name><surname>Wang</surname><given-names>X-W</given-names></name><name><surname>Yi</surname><given-names>S-H</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>G</given-names></name></person-group><article-title>Gene expression profile and enrichment pathways in different stages of bladder cancer</article-title><source>Genetics and Molecular Research</source><year>2013</year><volume>12</volume><issue>2</issue><fpage>1479</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.4238/2013.May.6.1</pub-id><pub-id pub-id-type="pmid">23765955</pub-id></element-citation></ref><ref id="ref-13"><label>Ghosh, Bhattacharyya &#x00026; Varga (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>AK</given-names></name><name><surname>Bhattacharyya</surname><given-names>S</given-names></name><name><surname>Varga</surname><given-names>J</given-names></name></person-group><article-title>The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells</article-title><source>Journal of Biological Chemistry</source><year>2004</year><volume>279</volume><issue>46</issue><fpage>47455</fpage><lpage>47463</lpage><pub-id pub-id-type="doi">10.1074/jbc.M403477200</pub-id><pub-id pub-id-type="pmid">15345715</pub-id></element-citation></ref><ref id="ref-14"><label>Giussani et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giussani</surname><given-names>M</given-names></name><name><surname>Landoni</surname><given-names>E</given-names></name><name><surname>Merlino</surname><given-names>G</given-names></name><name><surname>Turdo</surname><given-names>F</given-names></name><name><surname>Veneroni</surname><given-names>S</given-names></name><name><surname>Paolini</surname><given-names>B</given-names></name><name><surname>Cappelletti</surname><given-names>V</given-names></name><name><surname>Miceli</surname><given-names>R</given-names></name><name><surname>Orlandi</surname><given-names>R</given-names></name><name><surname>Triulzi</surname><given-names>T</given-names></name><name><surname>Tagliabue</surname><given-names>E</given-names></name></person-group><article-title>Extracellular matrix proteins as diagnostic markers of breast carcinoma</article-title><source>Journal of Cellular Physiology</source><year>2018</year><volume>233</volume><issue>8</issue><fpage>6280</fpage><lpage>6290</lpage><pub-id pub-id-type="doi">10.1002/jcp.26513</pub-id><pub-id pub-id-type="pmid">29521413</pub-id></element-citation></ref><ref id="ref-16"><label>He et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name></person-group><article-title>Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma</article-title><source>Diseases of the Esophagus</source><year>2017</year><volume>30</volume><issue>5</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/dote/dow018</pub-id></element-citation></ref><ref id="ref-17"><label>Je et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Je</surname><given-names>EM</given-names></name><name><surname>Gwak</surname><given-names>M</given-names></name><name><surname>Oh</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>MR</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Yoo</surname><given-names>NJ</given-names></name></person-group><article-title>Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability</article-title><source>Pathology</source><year>2013</year><volume>45</volume><issue>7</issue><fpage>645</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1097/PAT.0000000000000007</pub-id><pub-id pub-id-type="pmid">24247621</pub-id></element-citation></ref><ref id="ref-18"><label>Karagoz et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagoz</surname><given-names>K</given-names></name><name><surname>Lehman</surname><given-names>HL</given-names></name><name><surname>Stairs</surname><given-names>DB</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Arga</surname><given-names>KY</given-names></name></person-group><article-title>Proteomic and metabolic signatures of esophageal squamous cell carcinoma</article-title><source>Current Cancer Drug Targets</source><year>2016</year><volume>16</volume><issue>8</issue><fpage>721</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.2174/1568009616666160203113721</pub-id></element-citation></ref><ref id="ref-19"><label>Kita et al. (2009)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>Y</given-names></name><name><surname>Mimori</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Haraguchi</surname><given-names>N</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Matsuzaki</surname><given-names>S</given-names></name><name><surname>Fukuyoshi</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Natsugoe</surname><given-names>S</given-names></name><name><surname>Aikou</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name></person-group><article-title>Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma</article-title><source>European Journal of Surgical Oncology</source><year>2009</year><volume>35</volume><issue>1</issue><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ejso.2008.01.025</pub-id><pub-id pub-id-type="pmid">18331784</pub-id></element-citation></ref><ref id="ref-20"><label>Koskimaki et al. (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koskimaki</surname><given-names>JE</given-names></name><name><surname>Karagiannis</surname><given-names>ED</given-names></name><name><surname>Tang</surname><given-names>BC</given-names></name><name><surname>Hammers</surname><given-names>H</given-names></name><name><surname>Watkins</surname><given-names>DN</given-names></name><name><surname>Pili</surname><given-names>R</given-names></name><name><surname>Popel</surname><given-names>AS</given-names></name></person-group><article-title>Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model</article-title><source>BMC Cancer</source><year>2010</year><volume>10</volume><issue>1</issue><fpage>29</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-10-29</pub-id><pub-id pub-id-type="pmid">20122172</pub-id></element-citation></ref><ref id="ref-21"><label>Kosugi et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosugi</surname><given-names>S</given-names></name><name><surname>Nishimaki</surname><given-names>T</given-names></name><name><surname>Kanda</surname><given-names>T</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Ohashi</surname><given-names>M</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name></person-group><article-title>Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients</article-title><source>World Journal of Surgery</source><year>2004</year><volume>28</volume><issue>7</issue><fpage>680</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1007/s00268-004-6865-y</pub-id><pub-id pub-id-type="pmid">15383868</pub-id></element-citation></ref><ref id="ref-22"><label>Langfelder &#x00026; Horvath (2008)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfelder</surname><given-names>P</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>WGCNA: an R package for weighted correlation network analysis</article-title><source>BMC Bioinformatics</source><year>2008</year><volume>9</volume><issue>1</issue><fpage>559</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id><pub-id pub-id-type="pmid">19114008</pub-id></element-citation></ref><ref id="ref-23"><label>Lao-Sirieix &#x00026; Fitzgerald (2012)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lao-Sirieix</surname><given-names>P</given-names></name><name><surname>Fitzgerald</surname><given-names>RC</given-names></name></person-group><article-title>Screening for oesophageal cancer</article-title><source>Nature Reviews Clinical Oncology</source><year>2012</year><volume>9</volume><issue>5</issue><fpage>278</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2012.35</pub-id></element-citation></ref><ref id="ref-24"><label>Law et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Alhamdoosh</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Ritchie</surname><given-names>ME</given-names></name></person-group><article-title>RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR</article-title><source>F1000Research</source><year>2016</year><volume>5</volume><fpage>1408</fpage><pub-id pub-id-type="doi">10.12688/f1000research.9005.3</pub-id></element-citation></ref><ref id="ref-25"><label>Li et al. (2014)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>MY</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Skogerboe</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Shao</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Qiu</surname><given-names>B</given-names></name><name><surname>Tan</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma</article-title><source>Gut</source><year>2014</year><volume>63</volume><issue>11</issue><fpage>1700</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2013-305806</pub-id><pub-id pub-id-type="pmid">24522499</pub-id></element-citation></ref><ref id="ref-27"><label>Liu et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Tao</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>H</given-names></name></person-group><article-title>Role of COL6A3 in colorectal cancer</article-title><source>Oncology Reports</source><year>2018</year><volume>39</volume><issue>6</issue><fpage>2527</fpage><lpage>2536</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6331</pub-id><pub-id pub-id-type="pmid">29620224</pub-id></element-citation></ref><ref id="ref-28"><label>Lossos et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lossos</surname><given-names>IS</given-names></name><name><surname>Czerwinski</surname><given-names>DK</given-names></name><name><surname>Alizadeh</surname><given-names>AA</given-names></name><name><surname>Wechser</surname><given-names>MA</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name></person-group><article-title>Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes</article-title><source>New England Journal of Medicine</source><year>2004</year><volume>350</volume><issue>18</issue><fpage>1828</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa032520</pub-id><pub-id pub-id-type="pmid">15115829</pub-id></element-citation></ref><ref id="ref-29"><label>L&#x000fc;demann et al. (2006)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000fc;demann</surname><given-names>L</given-names></name><name><surname>Grieger</surname><given-names>W</given-names></name><name><surname>Wurm</surname><given-names>R</given-names></name><name><surname>Wust</surname><given-names>P</given-names></name><name><surname>Zimmer</surname><given-names>C</given-names></name></person-group><article-title>Glioma assessment using quantitative blood volume maps generated by T1-weighted dynamic contrast-enhanced magnetic resonance imaging: a receiver operating characteristic study</article-title><source>Acta Radiologica</source><year>2006</year><volume>47</volume><issue>3</issue><fpage>303</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1080/02841850500539033</pub-id><pub-id pub-id-type="pmid">16613313</pub-id></element-citation></ref><ref id="ref-30"><label>Mah et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mah</surname><given-names>EJ</given-names></name><name><surname>Lefebvre</surname><given-names>AEYT</given-names></name><name><surname>McGahey</surname><given-names>GE</given-names></name><name><surname>Yee</surname><given-names>AF</given-names></name><name><surname>Digman</surname><given-names>MA</given-names></name></person-group><article-title>Collagen density modulates triple-negative breast cancer cell metabolism through adhesion-mediated contractility</article-title><source>Scientific Reports</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>17094</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-35381-9</pub-id><pub-id pub-id-type="pmid">30459440</pub-id></element-citation></ref><ref id="ref-31"><label>McCarthy &#x00026; Hay (1991)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>RA</given-names></name><name><surname>Hay</surname><given-names>ED</given-names></name></person-group><article-title>Collagen I, laminin, and tenascin: ultrastructure and correlation with avian neural crest formation</article-title><source>International Journal of Developmental Biology</source><year>1991</year><volume>35</volume><fpage>437</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">1724907</pub-id></element-citation></ref><ref id="ref-32"><label>Metz (1978)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metz</surname><given-names>CE</given-names></name></person-group><article-title>Basic principles of ROC analysis</article-title><source>Seminars in Nuclear Medicine</source><year>1978</year><volume>8</volume><issue>4</issue><fpage>283</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/S0001-2998(78)80014-2</pub-id><pub-id pub-id-type="pmid">112681</pub-id></element-citation></ref><ref id="ref-33"><label>Morris et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>BA</given-names></name><name><surname>Burkel</surname><given-names>B</given-names></name><name><surname>Ponik</surname><given-names>SM</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Condeelis</surname><given-names>JS</given-names></name><name><surname>Aguirre-Ghiso</surname><given-names>JA</given-names></name><name><surname>Castracane</surname><given-names>J</given-names></name><name><surname>Denu</surname><given-names>JM</given-names></name><name><surname>Keely</surname><given-names>PJ</given-names></name></person-group><article-title>Collagen matrix density drives the metabolic shift in breast cancer cells</article-title><source>EBioMedicine</source><year>2016</year><volume>13</volume><fpage>146</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2016.10.012</pub-id><pub-id pub-id-type="pmid">27743905</pub-id></element-citation></ref><ref id="ref-34"><label>Nambara et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nambara</surname><given-names>S</given-names></name><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Tobo</surname><given-names>T</given-names></name><name><surname>Kidogami</surname><given-names>S</given-names></name><name><surname>Komatsu</surname><given-names>H</given-names></name><name><surname>Sugimachi</surname><given-names>K</given-names></name><name><surname>Saeki</surname><given-names>H</given-names></name><name><surname>Oki</surname><given-names>E</given-names></name><name><surname>Maehara</surname><given-names>Y</given-names></name><name><surname>Mimori</surname><given-names>K</given-names></name></person-group><article-title>Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma</article-title><source>Oncology Letters</source><year>2017</year><volume>14</volume><issue>2</issue><fpage>1795</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.3892/ol.2017.6341</pub-id><pub-id pub-id-type="pmid">28789412</pub-id></element-citation></ref><ref id="ref-35"><label>Obuchowski (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obuchowski</surname><given-names>NA</given-names></name></person-group><article-title>Receiver operating characteristic curves and their use in radiology</article-title><source>Radiology</source><year>2003</year><volume>229</volume><issue>1</issue><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1148/radiol.2291010898</pub-id><pub-id pub-id-type="pmid">14519861</pub-id></element-citation></ref><ref id="ref-36"><label>&#x000d6;hlund et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;hlund</surname><given-names>D</given-names></name><name><surname>Franklin</surname><given-names>O</given-names></name><name><surname>Lundberg</surname><given-names>E</given-names></name><name><surname>Lundin</surname><given-names>C</given-names></name><name><surname>Sund</surname><given-names>M</given-names></name></person-group><article-title>Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop</article-title><source>BMC Cancer</source><year>2013</year><volume>13</volume><issue>1</issue><fpage>154</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-13-154</pub-id><pub-id pub-id-type="pmid">23530721</pub-id></element-citation></ref><ref id="ref-37"><label>Pennathur et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennathur</surname><given-names>A</given-names></name><name><surname>Gibson</surname><given-names>MK</given-names></name><name><surname>Jobe</surname><given-names>BA</given-names></name><name><surname>Luketich</surname><given-names>JD</given-names></name></person-group><article-title>Oesophageal carcinoma</article-title><source>Lancet</source><year>2013</year><volume>381</volume><issue>9864</issue><fpage>400</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)60643-6</pub-id><pub-id pub-id-type="pmid">23374478</pub-id></element-citation></ref><ref id="ref-38"><label>Perris et al. (1993a)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perris</surname><given-names>R</given-names></name><name><surname>Kuo</surname><given-names>HJ</given-names></name><name><surname>Glanville</surname><given-names>RW</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><article-title>Collagen type VI in neural crest development: distribution in situ and interaction with cells in vitro</article-title><source>Developmental Dynamics</source><year>1993a</year><volume>198</volume><issue>2</issue><fpage>135</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1002/aja.1001980207</pub-id><pub-id pub-id-type="pmid">8305706</pub-id></element-citation></ref><ref id="ref-39"><label>Perris et al. (1993b)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perris</surname><given-names>R</given-names></name><name><surname>Kuo</surname><given-names>HJ</given-names></name><name><surname>Glanville</surname><given-names>RW</given-names></name><name><surname>Leibold</surname><given-names>S</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name></person-group><article-title>Neural crest cell interaction with type VI collagen is mediated by multiple cooperative binding sites within triple-helix and globular domains</article-title><source>Experimental Cell Research</source><year>1993b</year><volume>209</volume><issue>1</issue><fpage>103</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1006/excr.1993.1290</pub-id><pub-id pub-id-type="pmid">8223995</pub-id></element-citation></ref><ref id="ref-40"><label>Peters et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>DG</given-names></name><name><surname>Kudla</surname><given-names>DM</given-names></name><name><surname>Deloia</surname><given-names>JA</given-names></name><name><surname>Chu</surname><given-names>TJ</given-names></name><name><surname>Fairfull</surname><given-names>L</given-names></name><name><surname>Edwards</surname><given-names>RP</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name></person-group><article-title>Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression</article-title><source>Cancer Epidemiology Biomarkers &#x00026; Prevention</source><year>2005</year><volume>14</volume><issue>7</issue><fpage>1717</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-04-0704</pub-id></element-citation></ref><ref id="ref-41"><label>Phipson et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Majewski</surname><given-names>IJ</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression</article-title><source>Annals of Applied Statistics</source><year>2016</year><volume>10</volume><issue>2</issue><fpage>946</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1214/16-AOAS920</pub-id><pub-id pub-id-type="pmid">28367255</pub-id></element-citation></ref><ref id="ref-67"><label>R Core Team (2018)</label><element-citation publication-type="book"><person-group person-group-type="author"><collab><institution>R Core Team</institution></collab></person-group><source>R: a language and environment for statistical computing</source><year>2018</year><version designator="3.5.3">Version 3.5.3</version><publisher-loc>Vienna</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><uri xlink:href="https://www.R-project.org/">https://www.R-project.org/</uri></element-citation></ref><ref id="ref-42"><label>Ricard-Blum (2011)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricard-Blum</surname><given-names>S</given-names></name></person-group><article-title>The collagen family</article-title><source>Cold Spring Harbor Perspectives in Biology</source><year>2011</year><volume>3</volume><issue>1</issue><fpage>a004978</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a004978</pub-id><pub-id pub-id-type="pmid">21421911</pub-id></element-citation></ref><ref id="ref-43"><label>Ritchie et al. (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><name><surname>Phipson</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Research</source><year>2015</year><volume>43</volume><issue>7</issue><elocation-id>e47</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="ref-44"><label>Robinson, McCarthy &#x00026; Smyth (2010)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><issue>1</issue><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><pub-id pub-id-type="pmid">19910308</pub-id></element-citation></ref><ref id="ref-45"><label>Rong et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rong</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Chi</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><article-title>COL1A2 is a novel biomarker to improve clinical prediction in human gastric cancer: integrating bioinformatics and meta-analysis</article-title><source>Pathology &#x00026; Oncology Research</source><year>2018</year><volume>24</volume><issue>1</issue><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1007/s12253-017-0223-5</pub-id><pub-id pub-id-type="pmid">28401451</pub-id></element-citation></ref><ref id="ref-47"><label>Senthebane et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senthebane</surname><given-names>DA</given-names></name><name><surname>Jonker</surname><given-names>T</given-names></name><name><surname>Rowe</surname><given-names>A</given-names></name><name><surname>Thomford</surname><given-names>NE</given-names></name><name><surname>Munro</surname><given-names>D</given-names></name><name><surname>Dandara</surname><given-names>C</given-names></name><name><surname>Wonkam</surname><given-names>A</given-names></name><name><surname>Govender</surname><given-names>D</given-names></name><name><surname>Calder</surname><given-names>B</given-names></name><name><surname>Soares</surname><given-names>NC</given-names></name><name><surname>Blackburn</surname><given-names>JM</given-names></name><name><surname>Parker</surname><given-names>MI</given-names></name><name><surname>Dzobo</surname><given-names>K</given-names></name></person-group><article-title>The role of tumor microenvironment in chemoresistance: 3D extracellular matrices as accomplices</article-title><source>International Journal of Molecular Sciences</source><year>2018</year><volume>19</volume><issue>10</issue><fpage>2861</fpage><pub-id pub-id-type="doi">10.3390/ijms19102861</pub-id></element-citation></ref><ref id="ref-48"><label>Shen et al. (2016)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Miao</surname><given-names>C</given-names></name></person-group><article-title>COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance</article-title><source>Oncology Reports</source><year>2016</year><volume>36</volume><issue>2</issue><fpage>877</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.3892/or.2016.4869</pub-id><pub-id pub-id-type="pmid">27373316</pub-id></element-citation></ref><ref id="ref-49"><label>Smyth &#x00026; Speed (2003)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Speed</surname><given-names>T</given-names></name></person-group><article-title>Normalization of cDNA microarray data</article-title><source>Methods</source><year>2003</year><volume>31</volume><issue>4</issue><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/S1046-2023(03)00155-5</pub-id><pub-id pub-id-type="pmid">14597310</pub-id></element-citation></ref><ref id="ref-50"><label>S&#x000f6;derh&#x000e4;ll et al. (2007)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f6;derh&#x000e4;ll</surname><given-names>C</given-names></name><name><surname>Marenholz</surname><given-names>I</given-names></name><name><surname>Kerscher</surname><given-names>T</given-names></name><name><surname>R&#x000fc;schendorf</surname><given-names>F</given-names></name><name><surname>Esparza-Gordillo</surname><given-names>J</given-names></name><name><surname>Worm</surname><given-names>M</given-names></name><name><surname>Gruber</surname><given-names>C</given-names></name><name><surname>Mayr</surname><given-names>G</given-names></name><name><surname>Albrecht</surname><given-names>M</given-names></name><name><surname>Rohde</surname><given-names>K</given-names></name><name><surname>Schulz</surname><given-names>H</given-names></name><name><surname>Wahn</surname><given-names>U</given-names></name><name><surname>Hubner</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>Y-A</given-names></name></person-group><article-title>Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis</article-title><source>PLOS Biology</source><year>2007</year><volume>5</volume><issue>9</issue><elocation-id>e242</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0050242</pub-id><pub-id pub-id-type="pmid">17850181</pub-id></element-citation></ref><ref id="ref-51"><label>Sorushanova et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorushanova</surname><given-names>A</given-names></name><name><surname>Delgado</surname><given-names>LM</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Shologu</surname><given-names>N</given-names></name><name><surname>Kshirsagar</surname><given-names>A</given-names></name><name><surname>Raghunath</surname><given-names>R</given-names></name><name><surname>Mullen</surname><given-names>AM</given-names></name><name><surname>Bayon</surname><given-names>Y</given-names></name><name><surname>Pandit</surname><given-names>A</given-names></name><name><surname>Raghunath</surname><given-names>M</given-names></name><name><surname>Zeugolis</surname><given-names>DI</given-names></name></person-group><article-title>The collagen suprafamily: from biosynthesis to advanced biomaterial development</article-title><source>Advanced Materials</source><year>2018</year><volume>31</volume><issue>1</issue><elocation-id>e1801651</elocation-id><pub-id pub-id-type="doi">10.1002/adma.201801651</pub-id><pub-id pub-id-type="pmid">30126066</pub-id></element-citation></ref><ref id="ref-52"><label>Spruance et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spruance</surname><given-names>SL</given-names></name><name><surname>Reid</surname><given-names>JE</given-names></name><name><surname>Grace</surname><given-names>M</given-names></name><name><surname>Samore</surname><given-names>M</given-names></name></person-group><article-title>Hazard ratio in clinical trials</article-title><source>Antimicrobial Agents and Chemotherapy</source><year>2004</year><volume>48</volume><issue>8</issue><fpage>2787</fpage><lpage>2792</lpage><pub-id pub-id-type="doi">10.1128/AAC.48.8.2787-2792.2004</pub-id><pub-id pub-id-type="pmid">15273082</pub-id></element-citation></ref><ref id="ref-53"><label>Subramanian et al. (2005)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2005</year><volume>102</volume><issue>43</issue><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="ref-54"><label>Trifonov et al. (2013)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trifonov</surname><given-names>V</given-names></name><name><surname>Pasqualucci</surname><given-names>L</given-names></name><name><surname>Dalla Favera</surname><given-names>R</given-names></name><name><surname>Rabadan</surname><given-names>R</given-names></name></person-group><article-title>MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples</article-title><source>BMC Systems Biology</source><year>2013</year><volume>7</volume><issue>1</issue><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/1752-0509-7-25</pub-id><pub-id pub-id-type="pmid">23531283</pub-id></element-citation></ref><ref id="ref-55"><label>Wan et al. (2015)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>B</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name></person-group><article-title>Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients</article-title><source>Oncotarget</source><year>2015</year><volume>6</volume><issue>29</issue><fpage>27378</fpage><lpage>27387</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.4860</pub-id><pub-id pub-id-type="pmid">26317545</pub-id></element-citation></ref><ref id="ref-56"><label>Wang et al. (2004)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G-Q</given-names></name><name><surname>Jiao</surname><given-names>G-G</given-names></name><name><surname>Chang</surname><given-names>F-B</given-names></name><name><surname>Fang</surname><given-names>W-H</given-names></name><name><surname>Song</surname><given-names>J-X</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>D-M</given-names></name><name><surname>Xie</surname><given-names>Y-Q</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name></person-group><article-title>Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening</article-title><source>Annals of Thoracic Surgery</source><year>2004</year><volume>77</volume><issue>5</issue><fpage>1740</fpage><lpage>1744</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2003.10.098</pub-id><pub-id pub-id-type="pmid">15111177</pub-id></element-citation></ref><ref id="ref-57"><label>Wang et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Song</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Shang</surname><given-names>J</given-names></name><name><surname>Ju</surname><given-names>W</given-names></name></person-group><article-title>Construction of immune-related risk signature for renal papillary cell carcinoma</article-title><source>Cancer Medicine</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>289</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1002/cam4.1905</pub-id><pub-id pub-id-type="pmid">30516029</pub-id></element-citation></ref><ref id="ref-58"><label>Xu et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Chang</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Dai</surname><given-names>B</given-names></name><name><surname>Gan</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>D</given-names></name></person-group><article-title>The oncogenic Role of COL23A1 in clear cell renal cell carcinoma</article-title><source>Scientific Reports</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>9846</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-10134-2</pub-id><pub-id pub-id-type="pmid">28852123</pub-id></element-citation></ref><ref id="ref-59"><label>Yang et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Xuan</surname><given-names>Y</given-names></name></person-group><article-title>Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma</article-title><source>Journal of Cancer Research and Clinical Oncology</source><year>2017</year><volume>143</volume><issue>2</issue><fpage>243</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1007/s00432-016-2273-6</pub-id><pub-id pub-id-type="pmid">27680978</pub-id></element-citation></ref><ref id="ref-60"><label>Zeng et al. (2018)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X-T</given-names></name><name><surname>Liu</surname><given-names>X-P</given-names></name><name><surname>Liu</surname><given-names>T-Z</given-names></name><name><surname>Wang</surname><given-names>X-H</given-names></name></person-group><article-title>The clinical significance of COL5A2 in patients with bladder cancer: a retrospective analysis of bladder cancer gene expression data</article-title><source>Medicine</source><year>2018</year><volume>97</volume><issue>10</issue><elocation-id>e0091</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000010091</pub-id><pub-id pub-id-type="pmid">29517678</pub-id></element-citation></ref><ref id="ref-61"><label>Zhan et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Hai</surname><given-names>G</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Alterations in splenic function and gene expression in mice with depressive-like behavior induced by exposure to corticosterone</article-title><source>International Journal of Molecular Medicine</source><year>2017</year><volume>39</volume><issue>2</issue><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2017.2850</pub-id><pub-id pub-id-type="pmid">28075471</pub-id></element-citation></ref><ref id="ref-62"><label>Zhang et al. (2018c)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name></person-group><article-title>COL1A1: a potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS</article-title><source>International Journal of Oncology</source><year>2018c</year><volume>53</volume><fpage>1869</fpage><lpage>1880</lpage><pub-id pub-id-type="doi">10.3892/ijo.2018.4536</pub-id><pub-id pub-id-type="pmid">30132520</pub-id></element-citation></ref><ref id="ref-63"><label>Zhang et al. (2018b)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Lv</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Tian</surname><given-names>Z</given-names></name></person-group><article-title>Identification of the key transcription factors in esophageal squamous cell carcinoma</article-title><source>Journal of Thoracic Disease</source><year>2018b</year><volume>10</volume><issue>1</issue><fpage>148</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.21037/jtd.2017.12.27</pub-id><pub-id pub-id-type="pmid">29600044</pub-id></element-citation></ref><ref id="ref-64"><label>Zhang et al. (2018a)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name></person-group><article-title>Cytoplasmic collagen XI&#x003b1;I as a prognostic biomarker in esophageal squamous cell carcinoma</article-title><source>Cancer Biology &#x00026; Therapy</source><year>2018a</year><volume>19</volume><issue>5</issue><fpage>364</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1080/15384047.2018.1423915</pub-id><pub-id pub-id-type="pmid">29333916</pub-id></element-citation></ref><ref id="ref-65"><label>Zhang et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z-L</given-names></name><name><surname>Zhao</surname><given-names>L-J</given-names></name><name><surname>Chai</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>S-H</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y-P</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name></person-group><article-title>Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma</article-title><source>Scientific Reports</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>309</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-00252-2</pub-id><pub-id pub-id-type="pmid">28331188</pub-id></element-citation></ref><ref id="ref-66"><label>Zhao et al. (2017)</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Bao</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhai</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>L</given-names></name></person-group><article-title>Bioinformatic profiling identifies a glucose-related risk signature for the malignancy of glioma and the survival of patients</article-title><source>Molecular Neurobiology</source><year>2017</year><volume>54</volume><issue>10</issue><fpage>8203</fpage><lpage>8210</lpage><pub-id pub-id-type="doi">10.1007/s12035-016-0314-4</pub-id><pub-id pub-id-type="pmid">27900679</pub-id></element-citation></ref></ref-list></back></article>